Introduction {#Sec1}
============

Nanosilica, also known as the nanoform (\<100 nm) of silicon dioxide or silica nanoparticles (SiNPs), possesses distinct physico-chemical characteristics compared to its bulk form; smaller size materials have an increased surface-to-volume ratio and a higher surface reactivity (Oberdörster [@CR81]; Napierska et al. [@CR75]). Due to their appealing properties, SiNPs are now extensively used in agriculture, food, and consumer products including cosmetics (Napierska et al. [@CR75]; Khot et al. [@CR49]; Kasaai [@CR46]; Brinch et al. [@CR132]). Until 2012, nearly 1.5 million tons of SiNPs had already been placed in the global market (Liljenström et al. [@CR60]) and SiNPs became one of the three most produced nanomaterials (NMs) worldwide in 2013. Among the 846 nano-based products listed in a consumer products inventory, approximately 100 claim to contain SiNPs (Vance et al. [@CR92]). Moreover, amorphous SiNPs are being synthesized with highly tunable biocompatibility and stability, and considered as a very promising candidate for various bio-medical applications such as gene carrier, drug delivery, and molecular imaging (Tang and Cheng [@CR92]; Bitar et al. [@CR6]).

In recent years, large-scale industrial production and global commercialization of SiNPs have resulted in increased risk of human exposures at workplaces (Kim et al. [@CR50]; Oh et al. [@CR82]). Food additive silica (E551) is also in the nano size range (Dekkers et al. [@CR14]), indicating that the general population is probably more exposed than initially anticipated. Moreover, in view of the efforts to use NM in medical applications, SiNPs could also be intentionally introduced into the human body for disease diagnosis and treatments (Croissant et al. [@CR12]). Such growing potentials for exposure raised a global concern regarding the safety and potential adverse health effects of SiNPs.

Human health effects associated with silica exposure, especially crystalline silica (0.5--10 µm), have widely been studied. Occupational exposure to crystalline silica induces silicosis in workers (a fibrotic lung disease) and is also associated with lung cancer, emphysema, and pulmonary tuberculosis (Leung et al. [@CR56]). Conversely, natural amorphous silica is generally considered as less harmful, since the toxicological potential of silica has so far been linked to its crystallinity. Recent studies have revealed that amorphous SiNPs can be as reactive as crystalline particles (Turci et al. [@CR92]). In vivo, amorphous SiNPs are, however, cleared more rapidly from the lung, which may contribute to explain their lower pathogenic potential (Arts et al. [@CR3]). The human health effects of nanosilica remain to be clarified and toxicologists believe that exposure to SiNPs, due to their small size, may bring different adverse effects compared to micron-sized silica (Napierska et al. [@CR75]).

The comprehensive review of Napierska et al. ([@CR75]) suggested that exposure to SiNPs (1--100 nm) induced toxic effects in vitro (immortalized mammalian cell lines) and in vivo (rats and mice). Physico-chemical properties such as size, surface area, and surface features were found to play a key role in the toxicity of SiNPs. Importantly, Napierska concluded that physico-chemical properties of SiNPs differ based on their production method and, therefore, may cause different biological effects. However, no definite conclusions were made due to insufficient or no data available for,Detailed physico-chemical characterization of different types of SiNPs;Comparison of the toxicity of different types of SiNPs (based on their production process);Comparison of the toxicity mechanisms of amorphous SiNPs and crystalline silica;Exposure via different routes and adverse effects of chronic exposure in vivo;Correlation of in vitro and in vivo studies andPhysico-chemical properties for the safer design of SiNPs.

Therefore, the aim of this review is to summarize the toxicity studies of SiNPs published after the Napierska review ([@CR75]), critically discuss the outcomes, and to evaluate how these data gaps have been addressed (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Systematic selection of studies

Methodology {#Sec2}
===========

The selection criteria was similar to the method described in Vriens et al. ([@CR92]), which was used to construct the MOD-ENP-TOX nanotoxicity database.

Exclusion criteria {#Sec3}
------------------

To specifically focus on adverse health effects of SiNPs, papers reporting on other interventions such as ecotoxicity, synergistic effects, SiNPs doped with other materials, and therapy-based outcomes were excluded.

Inclusion criteria {#Sec4}
------------------

Papers reporting,physico-chemical characteristics such as primary size, shape, composition, and crystallinity;toxicological endpoints such as cytotoxicity, apoptosis/necrosis, genotoxicity, oxidative stress, immunotoxicity, and autophagy using immortalized cell lines or primary cells (experimental in vitro studies); andtoxic effects in laboratory-animals, more specifically in vivo experiments using rats and mice.

Literature search {#Sec5}
-----------------

We searched two databases for papers published from June 2010 (after Napierska et al. [@CR75]) to December 2016. In the PubMed "<http://www.ncbi.nlm.nih.gov/PubMed>" and EMBASE "<https://www.embase.com>" databases, the following keyword combinations were used: "silica nanoparticle" OR "silica NP" AND "toxicity" NOT "review". We retrieved a list of 859 and 405 articles in English, respectively. In a second step, duplicates were removed and the titles were screened to identify studies that best matched with our search terms, leaving 611 relevant papers. In a third step, we excluded papers that met the exclusion criteria and left 128 most relevant papers. Finally, 82 papers reporting a minimum set of physico-chemical characterization and toxic effects were selected for the main content of the review. Notably, only one study was found on the toxicity of crystalline nanosilica (Chu et al. [@CR9]), but it was finally excluded due to insufficient data on the size of particles. As a result, the review is dealing only with amorphous SiNPs.

Induction of oxidative stress is considered as the major mechanism involved in SiNPs toxicity (Wang et al. [@CR92]; Ye et al. [@CR92], [@CR92]) and, therefore, the in vitro section of the review was structured according to toxic endpoints and its association with oxidative stress. For in vivo, studies were sorted based on exposure route and modalities, since they can significantly influence the toxicokinetics of SiNPs. Throughout the review, the following abbreviations were used to indicate the different types of silica nanoparticles: SiNPs when it is not clear which type was used, C-SiNPs for colloidal silica; S-SiNP for stöber silica; M-SiNPs for mesoporous silica; Pr-SiNPs for precipitated silica; and Py-SiNPs for pyrogenic silica.

The table summarizing in vitro studies (Table [1](#Tab1){ref-type="table"}) was sorted according to the type of SiNPs (colloidal, stöber, mesoporous, pyrogenic, precipitated, and not specified) and cell types. Table [2](#Tab2){ref-type="table"} (in vivo studies) was organized according to the type of SiNPs and exposure routes.Table 1In vitro studies on SiNPs toxicityType of SiNPsCell lineCell typeParticle primary sizeSourceExposure doseExposure durationEndpointAssay(s)/method(s)ResultsReferencesC-SiNPsV79Hamster lung fibroblast9,15, 30, and 55 nmAkzoNobel AB10--600 µg/ml24 hCell viabilityTryphan blue exclusion and colony formation assayReduction with 15 nm NPsMaser et al. ([@CR67])A549Human type II alveolar epithelialGenotoxicityComet assayIncrease with 15 nm NPsC-SiNPsH441Human distal lung epithelial30 nmSigma-Aldrich0.6--600 µg/ml4--20 hCell viabilityMTS assayReduction at 600 µg/ml in monoculturesKasper et al. ([@CR47])ISO-HAS-1Human endothelialCytotoxicityLDH assayIncrease at 600 µg/ml in all culturesCellular barrier integrityTEER measurementReduction at 600 µg/ml in all culturesCo-culture: H441/ISO-HAS-1Human distal lung epithelial + human endothelialPro-inflammatory response(s)ELISAIncrease of siCAM-1, IL-6 and IL-8Cell morphologyHoechst stainingCells rounded at 600 µg/mlApoptosisWestern blotIncrease of apoptotic proteinsC-SiNPsA549Human type II alveolar epithelial70 nm---with or without lung surfactantMicromod Partikeltechnologie100 µg/ml4--20 hCell viabilityMTS and crystal violet assayReduction in monoculturesKasper et al. ([@CR48])CytotoxicityLDH assayIncrease in monoculturesPro-inflammatory response(s)ELISAIncrease of IL-8 in monocultures and co-culturesCo-culture: A549 and ISO-HAS-1Human type II alveolar epithelial + human endothelialCellular uptakeHoechst stainingIncrease in monocultures and co-culturesC-SiNPsCaco2Human colon epithelial15 nm (Levasil 200/40%) and 55 nm (Levasil 50/50%)H.C. Starck0.03--156.3 µg/cm^2^24, 48 and 72 hCell viabilityXTT assayDose-dependent reduction with 15 nm NPsTarantini et al. ([@CR92], [@CR92])Oxidative stressDCFH-DA assayDose-dependent increase with 15 nm SiNPsPro-inflammatory response(s)ELISAIncrease of IL-8 with 15 nm NPs only at 156.3 µg/cm^2^ApoptosisCaspase-3 assayDose-dependent increase with 15 nm NPsGenotoxicityMicronuclei inductionDose-dependent increase with 15 nm NPsGenotoxicityɣH2AX fluorescenceIncrease with 15 nm NPsNP internalizationTEMNPs detected in lysosomes and in endocytic compartmentsC-SiNPsHepG2Human liver epithelial19, 43, 68, and 498 nmLaboratory synthesis12--200 µg/ml24 hCell viabilityCCK-8 assaySize and dose-dependent reductionLi et al. ([@CR57])CytotoxicityLDH assaySize and dose-dependent increaseOxidative stressDCFH-DA assaySize-dependent increaseGenotoxicityComet assaySize-dependent increaseApoptosisApoptosis assaySize-dependent increaseCell cycle arrestFlow cytometrySize-dependent increaseCell morphologyH & E stainingCellular shrinkage, chromatin condensation and vacuolar degeneration detectedC-SiNPsRAW 264.7Mouse blood macrophage20 and 100 nm (uncoated or [l]{.smallcaps}-arginine coated)E&B Nanotech10--640 µg/ml24 hCell viabilityWST-8 assaySize and surface charge-dependent reductionKim et al. ([@CR51])C-SiNPs and M-SiNPsJ774A.1Mouse macrophage100 nmLaboratory synthesis0.1--1000 µg/ml24 and 72 hCell viabilityMTT assayReduction only for C-SiNPs SiNPsLee et al. ([@CR53])ApoptosisAnnexin V/PI stainingIncrease of caspase-3 activationPro-inflammatory response(s)RT PCR and western blotIncrease of TNF-α, IL-6 and IL-1βPathway analysisRT PCR and western blotActivation of MAPKs and NF-kBC-SiNPsJ744A.1Mouse macrophage25, 46, 183,182, and 188 nmSigma-Aldrich--24 hCell viabilityWST-1 assayED50: 6--9 µg/ml and 15--22 µg/ml in J774 and 3T3, ,respectivelyRabolli et al. ([@CR88])BALB/c3T3Mouse fibroblastIn vitro dosimetryISDD simulationSimilar delivered doses for all particle sizesC-SiNPsL5178Y/Tk^+/−^Mouse lymphoma7 nmSigma-Aldrich0.01--150 µg/ml4 hGenotoxicityLymphoma assayMutations detected at 100 and 150 µg/mlDemir and Castranova ([@CR17])C-SiNPsPBMCsLymphocytes, monocytes and dendritic cells10 and 100 nmPolysciences50--2000 µg/ml24 and 48 hCell viabilityFACSDose, time and size-dependent reductionMendoza et al. ([@CR70])Oxidative stressGSH depletionSize and dose-dependent increaseOxidative stressWestern-blotDose-dependent increase in proteins with free radicals only with 10 nmPro-inflammatory response(s)Multiplex bead arraySize and dose-dependent increase in cytokinesCell morphologyImmuno electron microscopySize-dependent increase in cell damageC-SiNPsHUVECHuman vein endothelial10, 50, 150, and 500 nmPolysciences10 nm--10 μg/ml\
50, 150 nm and 500 nm--50 μg/mL1 h (10 nm) and 3 h (50--500 nm)Oxidative stressFluorescent microscopyFree radical increaseCorbalan et al. ([@CR11])Pro-inflammatory response(s)Cytometric bead arraySize-dependent increase of IL-6 and IL-8Oxidative stressNanosensorsImbalance in \[NO\]/\[ONOO−\]Inflammatory factorsRT-PCRSize-dependent increase of ICAM1, VCAM1, SELE, MMP9, COX2 and F3NF-κB-binding activityELISAIncrease of NF-κB-binding activityNP internalizationTEMNPs detected in cytoplasm and vesiclesC-SiNPsPlateletsMouse50 nmPolysciences1, 5 and 25 µg/ml30 minPlatelet aggregationAggregation assayDose-dependent increaseNemmar et al. ([@CR78])CytotoxicityLDH assayDose-dependent increaseOxidative stressLPO assayDose-dependent increase of MDA formationCalcium concentrationFluorimeterIncrease in calcium concentration at 25 µg/mlC-SiNPsPlateletsHuman10, 50, 150, and 500 nmPolysciences1--200 μg/ml15 minPlatelet aggregationAggregation assaySize-dependent increaseJose Corbalan et al. ([@CR45])Oxidative stressNanosensorsSize-dependent increase of NOSELP and GPIIb/IIIa expressionFlow cytometryIncrease with 10, 100 and 150 nmMorphologyTEMPlatelets strongly aggregatedS-SiNPsA549Human type II alveolar epithelial2.1, 16.4, 60.4, and 104 nmLaboratory synthesis5 µg/cm^2^ of plate surface12--24 hCell viabilityMTT assaySize-dependent reductionNapierska et al. ([@CR77])THP-1Human monocyteCytotoxicityLDH assaySize-dependent increaseBiculture: A549/THP-1Lung co-culturesPro-inflammatory response(s)Cytometric bead arrayIncrease of all cytokines in the presence of 2 nm and 60 nm (except TNF-α)Triculture: A549/THP-1/EA.hy926Lung co-culturesS-SiNPsCo-culture: NCI-H441/ISO-HAS-1 with or without THP-1 cellsLung co-cultures15, 35, and 80 nmLaboratory synthesis50 and 100 µg/ml72 hOxidative stressDCFH-DA assayIncrease in the presence of THP-1Farcal et al. ([@CR27])Pro-inflammatory response(s)ELISAIncrease of IL-8 and TNF-αSurfactant protein expressionRT-PCRIncrease of surfactant proteins in the presence of THP-1Cellular barrier integrityTEER measurementNo effectS-SiNPsHepG2Human liver epithelial43 nmLaboratory synthesis25--200 µg/ml3 and 24 hOxidative stressDCFH-DA assayDose-dependent increaseSun et al. ([@CR97])Mitochondrial membrane potentialProbe measurementsDose-dependent increaseApoptosisAnnexin V/PI staining and western blotDose-dependent increaseCell morphologyTEMNPs detected in cytoplasm, mitochondria and lysosomesS-SiNPsHepG2Human liver epithelial62 nmLaboratory synthesis25--100 µg/ml24 hCell viabilityMTT assayDose-dependent reductionYu et al. ([@CR92])Oxidative stressDCFH-DA assayDose-dependent increaseAutophagyMDC stainingDose-dependent increaseAutophagyImmunoblotDose-dependent increase of LC3-II/LC3-INP internalizationLSCMNPs detected in cytoplasm and mitochondriaS-SiNPsLC-02Human liver epithelial50 nmLaboratory synthesis50--200 µg/ml24 hCell viabilityCCK-8 assayDose-dependent reductionWang et al. ([@CR92])Oxidative stressDCFH-DA assayDose-dependent increaseApoptosisAnnexin V/PI stainingDose-dependent increaseMitochondrial damageMitotracker/laser confocal microscopyDose-dependent increaseCell morphologyHoechst stainingDose-dependent increase in cell damageS-SiNPsHaCaTHuman keratinocyte50 nmLaboratory synthesis25--500 µg/ml4 hCell viabilityMTT assayDose-dependent reductionLiang et al. ([@CR59])CytotoxicityLDH assayDose-dependent increaseOxidative stressDCFH-DA assayDose-dependent increaseOxidative stressGSH depletionIncreaseApoptosisHoechst/PI stainingIncreaseNP internalizationTEMDetected in cytoplasmS-SiNPsEA.hy926Human endothelial16 (pure or iron-doped) and 60 nmLaboratory synthesis25 and 50 µg/ml24 hCell viabilityMTT assayReduction at 50 µg/ml with 16 nm NPsNapierska et al. ([@CR76])CytotoxicityLDH assayIncrease at 50 µg/ml with 16 nm NPsOxidative stressDCFH-DA assayDose-dependent increase only with Fe doped NPsOxidative stressGSH depletionDose-dependent increase only with Fe doped NPsOxidative stressLPO assayDose-dependent increase of MDA formation with Fe doped NPsOxidative stressRT-PCRIncrease with 16 nm NPsNP internalizationTEMNPs found in cytoplasmS-SiNPsHUVECHuman vein endothelial62 nmLaboratory synthesis25--100 µg/ml6, 12 and 24 hCell viabilityMTT assayDose-dependent reductionDuan et al. ([@CR22])CytotoxicityLDH assayDose-dependent increaseOxidative stressDCFH-DA assayDose-dependent increaseOxidative stressLPO assayDose-dependent increase of MDA formationOxidative stressSOD assayDose-dependent decreaseOxidative stressGSH Px assayDose-dependent decreaseApoptosisAnnexin V/PI stainingDose-dependent increaseMitochondrial membrane potentialProbe measurementsDose-dependent increaseGenotoxicityComet assayDose-dependent increaseCell cycle analysisWestern blotDose-dependent upregulation of chk 1 and down regulation Cdc25c, Cyclin B1, Cdc2NP internalizationLSCM and TEMNPs detected in cytoplasmS-SiNPsHUVECHuman vein endothelial62 nmLaboratory synthesis25--100 µg/ml24 hAutophagyMDC stainingDose-dependent increase of LC-3 II/LC3-IDuan et al. ([@CR23])AutophagyLSCM and TEMDose-dependent increase in cellular uptake and autophagic vacuoles, autophagosomes and autolysosomes detectedExpression of inflammatory factorsELISADose-dependent increase in the expression of CRP, TNF-α, IL-1β and IL-6Oxidative stressNO, NOS, eNOS and iNOS measurementsDose-dependent increase of iNOS and decrease of NO, NOS and eNOSPathway analysisWestern blotDose-dependent decrease of p-mTOR/mTOR, p-P13 K/P13 K and p- Akt/AktS-SiNPsHUVECHuman vein endothelial58 nmLaboratory synthesis12.5--100 µg/ml24 hCell viabilityMTT assayDose-dependent reductionGuo et al. ([@CR37])CytotoxicityLDH assayDose-dependent increaseOxidative stressDCFH-DA assayDose-dependent increaseOxidative stressGSH depletionDose-dependent increaseOxidative stressLPO assayDose-dependent increase of MDA formationOxidative stressSOD assayDose-dependent decreaseOxidative stressGSH-Px assayDose-dependent decreaseInflammatory factorsELISAIncrease of IL-1β, IL-8, TNFα, ICAM-1, VCAM-1, and MCP-1Oxidative stressNO, NOS, eNOS and iNOS measurementsDifferential expression of NO, iNOS and eNOS activity and downregulation of ET -1Pathway analysisRT-PCR and western blotDose-dependent increase of Nrf-2, p-ERK, p-JNK, p-p38 MAPK and NF-kBS-SiNPsHUVECHuman vein endothelial62 nmLaboratory synthesis25--100 µg/ml24 hCellular uptakeLSCMDose-dependent increaseDuan et al. ([@CR25])Cytoskeleton damageCell cytoskeleton stainingWeakening of F actin at 100 µg/mlMitochondrial membrane potentialProbe measurementsDose-dependent increaseAutophagyTEMAutophagic ultrastructures detectedAutophagyWestern blotIncrease of LC3-II/LC3-IInflammatory factorsWestern blotDecrease of ICAM-1 and VCAM-1Pathway analysisWestern blotDose-dependent decrease of p-mTOR/mTOR, p-P13K/P13K and p-Akt/AktS-SiNPsHUVECHuman vein endothelial58 nmLaboratory synthesis12.5--100 µg/ml24 hCell viabilityMTT assaySize and dose-dependent reductionGuo et al. ([@CR38])CytotoxicityLDH assaySize and dose-dependent increaseOxidative stressDCFH-DA assayIncreaseOxidative stressLPO, SOD and GSH assayIncreaseRedox relative factorsRT-PCRIncrease in Nrf2 activationApoptosisAO/EB stainingIncreaseMitochondrial membrane potentialProbe measurementsDecreaseAutophagyTEMAutophagosomes and autophagic vacuoles detectedCellular uptakeICP-AESIncreasePathway analysisWestern blotIncrease of MAPK/Bcl-2 and PI3 K/Akt/mTOR signalingS-SiNPs and M-SiNPsMPMCsMurine peritoneal mast cells25 nmLaboratory synthesis100 µg/ml24 hCell viabilityMTT assayReduction with non-porous NPsMaurer-jones et al. ([@CR68])RBCsHuman red blood cellsHemolysis of RBCsHemolysis assayIncrease with non-porous NPsCo-culture: MPMC/3T3Lung co-culturesCellular uptakeTEM and ICP-AESM-SiNPs NPs internalized more than non-porousS-SiNPs and M-SiNPsA549Human type II alveolar epithelial115 nm (with or without amine modification)Laboratory synthesis10, 50, 100, 250 and 500 μg/ml24 hCell viabilityWST-8 assayDose-dependent reduction only in RAW 264.7. Amine modified SiNPs were less toxicYu et al. ([@CR92])RBCsHuman red blood cellsRAW 264.7Mouse macrophageHemolysis of RBCsHemolysis assayIncrease only with M-SiNPsCytotoxicityPI stainingIncrease with M-SiNPsCellular uptakeICP-MSS-SiNPs internalized more than M-SiNPsM-SiNPsHT-29Human colon epithelial25 and 100 nmLaboratory synthesis10--150 µg/ml24 hCell viabilitySRBNo reductionSergent et al. ([@CR92])Cell viabilityImpedancemetryNo reduction with 25 nm NPs; higher toxicity at lower doses with 100 nm NPsCell viabilityFlow cytometryLimited toxicity with 25 nm; higher toxicity at lower doses with 100 nm NPsGenotoxicityɣH2AX fluorescenceNo effect with 25 nm; greater DNA damage at lower doses with 100 nm NPsM-SiNPsNRK-52ERat kidney epithelial198 nmLaboratory synthesis25--1000 µg/ml3 and 24 hCell viabilityMTT assayDose-dependent reductionChen et al. ([@CR8])CytotoxicityLDH assayDose-dependent increaseExpression of inflammatory factorsWestern blotDose-dependent increase of FN, TGF-β, and ICAM-1 (50--400 μg/ml)Pathway analysisImmuno-fluorescence stainingDose-dependent increase in the expression of NF-κB p65 (50--400 μg/ml)M-SiNPsHEK293Human kidney epithelial100 nm, 2.3 nm pore sizeLaboratory synthesis100 µg/ml24, 48 and 72 hCellular morphologyTEMCells shrunk and nucleus condensedZhang et al. ([@CR92])Oxidative stressFluorescent dihydroethi-diumNo effectOxidative stressRT PCRNo effectChromosomal aberrationsFISH assayNo effectMutationsEGFR and KRASNo effectGenotoxicityHuman mRNA micro array579 genes upregulated and 1263 genes downregulatedM-SiNPsEA.hy926Human endothelial48 nm (surface functionalized with PET and TMS)Laboratory synthesis20--1000 µg/ml at a flow rate of 30 µl/min using a microfluidic device--Cell viabilityTryphan blueNo effectKim et al. ([@CR50])Platelets (activated and non-activated)HumanPlatelet adhesionAdhesion assayIncrease at 1000 µg/mlPlatelet aggregationAggregation assayIncrease at 1000 µg/mlMorphologyFluorescent fixed cell imagingLarge aggregate formation at 1000 µg/mlPy-SiNPs and S-SiNPsA549Human type II alveolar epithelial12 (Py-SiNPs) and 50 nm(S-SiNPs)Py-SiNPs---Evonik; S-SiNPs---Landsberg am Lech52 μg/cm^2^ and 117 μg/cm^2^ (ALI)\
15.6 μg/cm^2^ (sub-merged)ALI (5 and 7 h)\
Sub-merged (24 h)CytotoxicityLDH assayDose-dependent increasePanas et al. ([@CR85])Pro-inflammatory responseELISAIncrease in IL-8Expression of inflammatory factorsWestern blotIncrease in the expression of COX-2 and phosphorylated p38; stronger effects observed in sub-merged culturePr-SiNPsA549Human type II alveolar epithelial15 nmNanoamor25--200 µg/ml72 hCell viabilityMTT assayDose-dependent reductionAhamed ([@CR1])A431Human skin epithelialCytotoxicityLDH assayDose-dependent increaseOxidative stressDCFH-DA assayDose-dependent increaseOxidative stressLPO assayDose-dependent increase of MDA formationOxidative stressGSH depletionDose-dependent increaseApoptosisRT PCRDose-dependent increase of caspase 3 and caspase 9Pr-SiNPs (NM-200) and Py-SiNPs (NM-203); NRT-808, NRT-817, NRT-820 and NRT-944Immortalized balb/3T3Mouse fibroblast10--25, 5--30, 15,35, 80, and 90 nmNM-JRC repository; NRT-Laboratory synthesis1--100 µg/ml72 hCell viabilityMTT assayReduction with 15 nm NPsUboldi et al. ([@CR92])Cell viabilityColony formation assayNo effectCell viabilityCell transformation assayNo effectGenotoxicityMicronuclei inductionNo effectNP internalizationFluorescent microscopyNPs detected in cytoplasmTwo Py-SiNPs samples (different sizes) one Pr-SiNPs and two C-SiNPs (different sizes)V79Hamster lung fibroblast20--80 nmSiNPs12.5--100 µg/cm^2^24 hCell viabilityWST-1 assayDose-dependent reductionGuichard et al. ([@CR36])Oxidative stressDCFH-DA assayNo effectApoptosisCaspase-3 assayDose-dependent increaseGenotoxicityFPG modified comet assayDose-dependent increaseGenotoxicityMicronuclei inductionNo effectMutationHPRT testNo effectPy-SiNPs(12 and 40 nm) and S-SiNPs (200 nm)HT-29Human colon epithelial12, 40, and 200 nmPy-SiNPs---Evonik; S-SiNPs---Angström Sphere0.03--156.3 µg/cm^2^24 hCell viabilityWST-1 assaySize-dependent reductionGehrke et al. ([@CR32])Cell viabilitySRB assaySize-dependent reductionCytotoxicityLDH assaySize-dependent increaseOxidative stressDCFH-DA assayNo effectOxidative stressGSH depletionDose-dependent increase with 12 nm NPsPathway analysisWestern blotDose-dependent increase of ERK1/2 phosphorylation with 12 nmPy-SiNPsC2BBe1Human colon epithelial12 nmSigma-Aldrich10 µg/cm^2^Acute---24 h\
Chronic---29 passagesCell viabilityMTT assayNo effectMcCracken et al. ([@CR69])CytotoxicityLDH assayNo effectApoptosisAnnexin V/PI stainingNo effectNecrosisSytox red stainingNo effectCellular uptakeTEMUptake only by a fraction of cellsPy-SiNPs and Pr-SiNPsGES-1Human gastric epithelial10--50 nmEvonik and Haihua10--600 µg/ml24, 48 and 72 hCell viabilityCCK-8 assaySize and dose-dependent reductionYang et al. ([@CR92])Caco2Human colon epithelialCytotoxicityLDH assaySize and dose-dependent increaseOxidative stressDCFH-DA assayNo effectApoptosisApoptosis assayNo effectCell cycle arrestCell cycle assayIncrease at S phase for GES cells and G2/M for caco2 cellsCellular uptakeTEMNPs detected in cytoplasmCellular morphologyUltramicrotome and TEMIncrease in cell damageCellular barrier integrityTEER measurementNo effectPy-SiNPs (NM 203) and Pr-SiNPs (NM 202)MH-S and RAW 264.7Mouse macrophages14 nmJRC repository5 or 10 µg/cm^2^24 hCytotoxicityHCSAPy-SiNPs induced greater reduction than Py-SiNPsDi Cristo et al. ([@CR18])Cellular uptakeHe Ion microscopy and flow cytometryHigher for Py-SiNPsMacrophage activationRT-PCRIncreasePro-inflammatory cytokinesELISAIncrease of TNF-α, IL-6 and IL-1βOxidative stressFluorescence microscopyNo ROS inductionPr-SiNPsHePG2Human liver epithelial14 nmNanoamor1--200 µg/ml72 hCell viabilityMTT and NRU assayDose-dependent reduction at 25--200 µg/mlAhmad et al. ([@CR2])Oxidative stressDCFH-DA assayDose-dependent increaseOxidative stressLPO assayDose-dependent increase MDA formationOxidative stressGSH depletionDose-dependent increaseApoptosisRT PCR and western blotUp regulation of p53, bax, and caspase 3 and down regulation of bcl 2ApoptosisCaspase-3 assayDose-dependent increasePr-SiNPs (NM 200 & 201), Py-SiNPs (NM 202 & 203)Human peripheral lymphocytesHuman14--16 nmJRC repository200--1250 µg/ml24 hGenotoxicityCytokinesis block micronuclei inductionNo effectTavares et al. ([@CR99])S-SiNPsPrimary Microglial cellsRat macrophage like cells150--200 nmLaboratory synthesis0.0728--7.28 µg/ml24 hCell viabilityMTS assayNo effectChoi et al. ([@CR200])CytotoxicityLDH assayNo effectOxidative stressDCFH-DA assayNo effectNO productionDAF-FM assayNo effectPro-inflammatory response(s)LuminexReduction in TNF-α. A small amount of IL-β detectedInflammatory factorsRT-PCRIncrease in COX-2Reverse microemulsionHK-2Human kidney epithelial20 and 100 nmLaboratory synthesis5--500 µg/ml24,48 and 72 hCell viabilityWST-1 and clonogenic assaySize, dose and time-dependent reductionPassagne et al. ([@CR87])LLC PK-1Porcine kidney epithelialOxidative stressLPO assayDose-dependent increase of MDA formationOxidative stressFluorescent dihydroethi-diumDose-dependent increaseOxidative stressRT-PCRUpregulation of anti-oxidant genesCellular uptakeTEMInternalization of particlesSiNPsA549Human type II alveolar epithelial20 nm (with or without amine or carboxyl coated)Laboratory synthesis200--1000 µg/ml12--48 hCell viabilityPI stainingReduction above 250 µg/mlNowak et al. ([@CR80])AutophagyMDC stainingThreefold and fivefold increase at 100 and 1000 µg/ml ,respectivelyAutophagyRT-PCRATG-12 and BECN genes upregulated at 1000 µg/mlCellular uptakeImmunostaining and fluorescent microscopyFunctionalized particles efficiently taken up than bare SiNPsCellular morphologyTEMCell blebbing detectedSiNPsBEAS-2BHuman bronchial epithelial20--40 nmSigma-Aldrich1 µg/ml24 hCell viabilityMTT assay, flow cytometryReduction in cell viabilityEom and Choi ([@CR26])Oxidative stressDCFH-DA assayIncrease in ROS productionPathway analysisWestern blotIncrease in HO-1, Nrf-2 and ERK phosphorylationSiNPsHFL-1Human lung fibroblast20 and 80 nmLaboratory synthesis250--2000 µg/ml48 hCell viabilityMTT assaySize and dose-dependent reductionXu et al. ([@CR92])Oxidative stressDCFH-DA assaySize and dose-dependent increaseApoptosisFlow cytometrySize and dose-dependent increaseApoptotic pathway analysisWestern blotIncrease of p53 and differential expression of cytochrome C, Bax, Bcl‐2, caspase, β‐actin and COX IVSiNPsMRC-5Human lung fibroblast4--13 nmNaBond Technologies12.5--62.5 µg/ml for 24, 48 and 72 h (cell viability)\
Other assays---62.5 µg/mlCell viability---48 and 72 h\
Other assays---24, 48 and 72 hCell viabilityMTT assayTime and dose-dependent reductionVoicu et al. ([@CR92])Oxidative stressDCFH-DA assayTime-dependent increaseOxidative stressGSH depletionTime-dependent increaseAdvanced oxidation protein productsWestern blotTime-dependent increaseApoptosisPI stainingTime-dependent increaseAutophagyMDC stainingTime-dependent increase of LC-3 II/LC3-ICellular morphologyH & E stainingVacuolization of cytoplasm detectedSiNPsA549Human type II alveolar epithelial30 nmNanoamor0.0--100 µg/ml24 hCell viabilityMTT assayDose-dependent reduction in A549Michael Berg et al. ([@CR71])MeT-5AHuman bronchial epithelialOxidative stressDCFH-DA assayDose-dependent increase in A549Oxidative stressGSH depletionDose-dependent increase in A549Oxidative stressWestern blot and RT PCRDifferential expression of anti-oxidant proteinsOxidative stressNrf 2 ImmunofluorescenceIncrease of Nrf 2 in A549Oxidative stressCatalase assayDose-dependent increaseSiNPsHFL-1Human lung fibroblast20 nmNanjing High Technology of Nano250--1500 µg/ml48 hCell viabilityMTT assayDose-dependent reductionZhang et al. ([@CR92])ApoptosisFluorescence microscopyDose-dependent increaseCellular morphologyPhase contrast microscopyDetection of morphological changes and NPs accumulationSiNPsHaCaTHuman keratinocyte15, 30, 100, and 5000 nmWan Jing New Material Co. Ltd and Sigma-Aldrich (5000 nm)0.5--100 µg/ml24 hCell viabilityCCK-8 assaySize and dose-dependent reductionGong et al. ([@CR35])Oxidative stressDCFH-DA assaySize and dose-dependent increaseApoptosisAnnexin V/PI stainingSize and dose-dependent increaseGenotoxicity8-OH-dGSize and dose-dependent increaseGenotoxicityɣH2AX fluorescenceSize and dose-dependent increaseGenotoxicityComet assaySize and dose-dependent increaseCellular morphologyMicroscopyMorphology affected at 10 µg/mlSiNPsHaCaTHuman keratinocyte70, 300, and 1000 nmMicromod Partikeltechnologie10--1250 µg/ml24 hCytotoxicityLDH assayDose-dependent increaseNabeshi et al. ([@CR73])Oxidative stressDCFH-DA assayDose-dependent increaseOxidative stressHydroxyl fluorescein assayDose-dependent increaseGenotoxicity8-OH-dGIncrease in tail length and tail momentCellular uptakeAssessment using Cytochalasin D and apocyninInternalization of NPs by NADPH oxidase independent endocytosisSiNPsHaCaTHuman keratinocyte70, 300, and 1000 nmMicromod Partikeltechnologie100 µg/ml24 hNP internalizationTEM70 nm NPs into the nucleus and 300 and 1000 nm SiNPs only in endosomesNabeshi et al. ([@CR74])GenotoxicityComet assayIncrease in tail length with 70 nm NPsSiNPsHepG2Human liver epithelial7, 20, and 50 nmShanghai Cabot Chemical20--640 µg/ml24, 48 and 72 hCell viabilityMTT assayDose and time-dependent reductionLu et al. ([@CR63])LC-02Human hepatocyteOxidative stressDCFH-DA assayIncrease in HepG2Oxidative stressGSH depletionIncrease in HepG2ApoptosisAnnexin V/PI stainingDose-dependent increase in HepG2SiNPs;Kupffer cellsRat liver macrophage15 nmSigma-Aldrich50--800 µg/ml\
Supernatant was incubated with BRL cells24 hCell viabilityCCK-8 assayDose-dependent reduction in BRLChen et al. ([@CR7])BRFRat liver cellsCytotoxicityLDH assayDose-dependent increase in BRLOxidative stressDCFH-DA assayDose-dependent increase in KCsOxidative stressGSH depletionDose-dependent increase in KCsPro-inflammatory responseELISADose-dependent increase of TNF-α in KCsNO productionGriess reagentDose-dependent increase of NO in KCsCellular morphologyPhase contrast microscopyCell damage observed for BRLSiNPsRAW 264.7Mouse macrophage12 nmSigma-Aldrich200 and 400 µg/ml24 hCell viabilityWST-8 assayDose-dependent reductionHashimoto and Imazato ([@CR40])GenotoxicityHoechst/PI stainingDeformation of nuclei at both concentrationsGenotoxicityComet assayDose-dependent increaseGenotoxicityMicronuclei inductionIncreaseCellular uptakeSEM and TEMNPs detected in vesicles and in nucleusSiNPsHuman peripheral lymphocytesHuman10--20 nmSigma-Aldrich50--100 µg/ml24 hCell viabilityMTT assayDose-dependent reductionRajiv et al. ([@CR91])CytotoxicityLDH assayDose-dependent increaseOxidative stressDCFH-DA assayDose-dependent increaseOxidative stressLPO assayDose-dependent increase of MDA formationOxidative stressGSH depletionDose-dependent increaseOxidative stressSOD assayDose-dependent decreaseOxidative stressCatalase assayDose-dependent increaseGenotoxicityComet assayIncreaseChromosomal aberrationsGiemsa staining and microscopyNo effectSiNPsPrimary microglial cellsRat brain macrophage like cells20 nmSigma-Aldrich250 and 500 mg/ml24 hCell viabilityMTT assayNo reductionXue et al. ([@CR92])PC12Rat neuron like cellsPro-inflammatory responseELISAMild increase of cytokines such as IL-6, TNF-α and IL-1βNO productionGriess reagent assayNo effectNuclear binding activityRT-PCRNo effectInflammatory factorsWestern blotNo effectSiNPsPC12Rat neuron like cells25± nmSaint Louis25--200 µg/ml24 hα-Synuclein levelsWestern blotDose-dependent increaseXie and Wu ([@CR92])Cellular uptakeTEMIncreaseAutophagyWestern blotDose-dependent Increase of LC-II and Beclin 1Pathway analysisWestern blotDose-dependent decrease of PI3K-Akt-mTOR signalingSiNPsRAW 264.7Mouse macrophage10, 50, 300, and 1000 nm (with and without amine modification)Micromod Partikeltechnologie6.25--100 µg/m (with LPS and PGN)24 hCell viabilityWST-8Dose and size-dependent reduction (only for bare SiNPs)Uemura et al. ([@CR92])Pro-inflammatory responsesELISADose-dependent increase of TNF-α and decrease of IL-6 (only for bare SiNPs). IL-6 decrease for micro particles*TEER* Transepithelial electrical resistance, *RT-PCR* Reverse transcription polymerase chain reaction, *ISDD* In vitro sedimentation, diffusion and dosimetry model, *FACS* Fluorescence-activated cell sorting, *LSCM* Laser scanning confocal microscopy, *AO/EB* Acridine orange/ethidium bromide, *FISH* Fluorescence in situ hybridization, *EGFR* Epidermal growth factor receptor, *KRAS* Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, *HPRT* Hypoxanthine phosphoribosyl transferase, *HSCA* High content screening and analysis, *DAM-FM* 4-amino-5-methylamino-2′,7′-difluorescein, *PI* Propidium iodide, *Nrf 2* Nuclear factor erythroid 2-related factor 2 Table 2In vivo studies on SiNPs toxicityType of SiNPsExposure routePrimary particle sizeSourceSpecies and StrainExposure doseExposure durationOrgan(s)/sample(s)Effect(s)/endpoint(s)Assay (s)/method(s)ResultsReferencesC-SiNPsOral20 and 100 nmE&B NanotechRat; SD (female and male)500 and 1000 mg/kg bw1 h--10 daysAnimalClinical signsObservationNo animal deathLee et al. ([@CR54])Lungs, liver, brain, kidneys, testis and spleenTissue distributionMolybdenum blue methodNPs detected in lungs, liver, spleen and kidneysNP LocalizationTEMNPs detected in the nuclei of hepatocytesUrine and fecesExcretion kineticsMolybdenum blue methodMost NPs excreted via fecesC-SiNPsOral20 and 100 nm (uncoated or [l]{.smallcaps}-arginine coated)E&B NanotechMice; C57BL/6750 mg/kg bwDaily for 14 daysBloodWBCs countSerum analyzerIncreaseKim et al. ([@CR51])Pro-inflammatory response(s)Multiplex analysisDifferential expression of cytokinesSpleenOxidative stressDCFH-DA assayIncreaseOxidative stressSOD and GPx assayNo effectOxidative stressGriess reagent/NO productionIncreaseC-SiNPsOral12 nmABC NanotechRat; SDAcute-1959 and 2061; Sub-acute-489.8, 979.5, 1959; Sub-chronic: 244.9, 489.8 and 975.9 mg/kg bwAcute---14 days\
Sub-acute---daily for 14 days\
Sub-chronic: daily for 13 wBloodBlood cell countHematoanalyzerNo effectYun et al. ([@CR92])Organ damage bio-markersSerum analyzerNo effectUrineUrinalysisUrine analyzerNo effectEyeOphthalmologyMorphological examinationNo effectMajor organsTissue distributionICP-MSNPs not detectedUrine and fecesExcretion kineticsICP-MSMost NPs excreted via fecesC-SiNPsOral gavage20 and 80 nm, coated with [l]{.smallcaps}-arginineE&B NanotechRats; Crl:CD(SD)500, 1000 and 2000 mg/kg bwDaily for 90 daysAnimalClinical signsObservationNo animal deathKim et al. ([@CR52])BloodBlood cell countHematoanalyzerNo effectOrgan damage bio-markersSerum analyzerNo effectEyeOphthalmologyObservation of ocular fundusNo effectAll major organsNecropsyWeighing organsNo effectHistopathologyH & E stainingNo effectC-SiNPsIntratracheal9,15, 30 and 55 nmAkzoNobel ABRat; Wistar (female)360 µg in 500 ml of saline3 daysBloodBlood cell countHematoanalyzerIncrease of polymorphonulcear neutrophils and lymphocytesMaser et al. ([@CR67])LungsHistopathologyH & E stainingMild increase of granulomatous inflammationGenotoxicityComet assayNo effectBone marrowGenotoxicityMicronucleus testNo effectC-SiNPsDermal20 nm, coated with [l]{.smallcaps}-arginineE&B NanotechRat; Sprague--Dawley (SD)500 mg, 1000 mg, and 2000 mg/kg bwDaily for 90 daysAnimalClinical signsObservationNo animal deathRyu et al. ([@CR92])BloodBlood cell countHematoanalyzerNo effectOrgan damage bio-markersSerum analyzerNo effectAll major organsNecropsyOrgan weighingNo effectHistopathologyH & E stainingNo effectC-SiNPsDermal20 and 100 nm (uncoated or [l]{.smallcaps}-arginine coated)E&B NanotechRat2000 (coated) and 1000 mg/kg bw(uncoated)Daily for 28 dBrainBlood--brain barrier damageEvans blue stainingNo effectShim et al. ([@CR92])Tissue distributionTEM-EDXNPs not detectedC-SiNPsIntraperitoneal50 nmPolysciencesMice; Male tuck ordinary0.25 mg/kg bw24 hBloodBlood cell countHematoanalyzerIncrease of leukocytesNemmar et al. ([@CR79])Organ damage bio-markersSerum analyzerIncrease of CK, ALT and ASTLungs, heart, liver, kidneys, and brainOxidative stressLPO, SOD and catalase assayIncreasePro-inflammatory response(s)ELISADifferential expression of IL-6, TNF-α and IL-1βGenotoxicityComet assayIncreaseC-SiNPsIntravenous64 nmLaboratory synthesisMice; ICR (male and female)0, 29.5, 103.5, and 177.5 mg/kg bw14 daysBloodOrgan damage bio-markersSerum analyzerIncrease of LDH, ALT and ASTYu et al. ([@CR92])Liver, spleen, kidneys, heart, lungs, and brainHistopathologyH & E stainingTissue damages observedCD-68 positive cellsCD-68 stainingIncrease in liver and spleenNP localizationTEMNPs detected in liver macrophages and in the endothelial cells of lungs and kidneysTissue distributionICP-OESSi detected in liver and lungsS-SiNPsIntratracheal50 nm, with or without amine modificationLaboratory synthesisMice; C57BL/6 (male)4 and 20 mg/kg bw24 hLungsInflammationBALF cell count and LDH assayDose-dependent increase of total cell number, macrophages, neutrophils and LDH releaseMorris et al. ([@CR72])Oxidative stressROS/RNS productionDose-dependent increaseS-SiNPsIntratracheal58 nmLaboratory synthesisMice; C57 (male)2 mg/kg bwOnce every 3 days for 45 daysTestisHistopathologyH & E stainingDecrease in mature sperm and primary spermatocytesZhang et al. ([@CR92])Meiotic regulating factorsWestern blotCell cycle arrest observedOxidative stressDCFH-DA assayIncreaseSpermQuality evaluationMicroscopyNo effectS-SiNPsIntratracheal43 nmLaboratory synthesisMice; BALB/c(female)0, 7, 21, and 35 mg/kg bwOnce every 3 days for 15 daysLungs, liver and heartHistopathologyH & E stainingIncrease of InflammationYang et al. ([@CR92])Organ damage bio-markersSerum analyzerIncrease of BUN, CREA, uric acid, and ASTNP localizationTEMNPs detected in cytoplasm and lysosomesMacrophage activationImmunohistochemistryIncreaseInflammatory responseMultiplex flow cytometryIncrease of IL-8, TNF-α and IL-6Duan et al. ([@CR24], [@CR25])S-SiNPsIntravenous62 nmLaboratory synthesisMice; ICR29.5, 103.5, and 177.5 mg/kg bw14 daysHeartAutophagyLC3 and VEGFR2 positive stainingIncrease of LC3TEMIncrease of autophagic ultrastructuresCell cytoskeleton stainingWeakening of F actinMMP measurementsDose-dependent decreaseLC3-II/LC3-I ratioIncreaseM-SiNPsIntragastricalSpherical 83 nm, short rods (AR 1.75) and long rods (AR 5)Laboratory synthesisMice; ICR (male)40 mg/kg bw14 daysBloodBlood cell countHematoanalyzerNo effectLi et al. ([@CR58])Organ damage bio-markersSerum analyzerIncrease of LDH release and CREALiver, kidneys, spleen, lungs and small intestineHistopathologyH & E stainingGross tissue damage in kidneysTissue distribution and excretion kineticsICP-OES and TEMshape-dependent distribution and clearance in organsM-SiNPsIntravenous1.5 (short rods) and 5 (long rods) aspect ratio; standard or PEGylatedLaboratory synthesisMice20 mg/kg bw2 h, 24 h and 7 daysBloodBlood cell countHematoanalyzerNo effectHuang et al. ([@CR44])Organ damage bio-markersSerum analyzerIncrease of TBIL, CREA and BUNLiver, spleen, lungs and kidneysHistopathologyDAPIGross tissue damage in kidneysTissue distributionICP-OESPEGylation reduced distribution in liver and spleenUrine and fecesExcretion kineticsTEM/EDXShort rods cleared rapidly than long rodsM-SiNPsIntraperitoneal\~198 nmLaboratory synthesisMice; BALB/C150, 300, and 600 mg/kg bw2 and 12 daysBloodOrgan damage bio-markersSerum analyzerIncrease of AST, ALT BUN and CREAChen et al. ([@CR8])KidneysHistopathologyH & E stainingDetection of renal interstitial fibrosisTissue damageMasson's trichrome stainingDose and time-dependent increase in kidney injuryPr-SiNPs (NM 200 & 201), Py-SiNPs (NM 202 & 203)Oral gavage18--24 nmJRC repositoryRat; SD (male)5, 10, and 20 mg/kg bw0, 24, and 45 hBloodOxidative stressLPO assayNo effectTarantini et al. ([@CR92], [@CR92])Liver, kidneys, spleen, intestine, blood and bone marrowHistopathologyH & E stainingNo effectGenotoxicityAlkaline, FpG modified comet assay and micronucleus testNo effectPr-SiNPs (NM 200)Oral gavage10--15 nmJRC repositoryRat; Wistar100, 300, or 1000 mg/kg bw at a dose volume of 10 mL/kg bwDaily for 14 days (from gestation period 6--19)AnimalClinical signsObservationNo animal deathHofmann et al. ([@CR201])Body weightObservationNo effectGravid uterusNecropsyCesareanNo effectFetusFetus gross damageMorphological examinationsNo effectPy-SiNPsExposure via food7 nm and NM 202 (10--25 nm)JRC repositoryRat; SDSub-acute: 100, 1000,2500 mg/kg bw\
Sub-chronic: 2500 mg/kg bwSub-acute: daily for 28 days\
Sub-chronic: daily for 84 daysBloodOrgan damage bio-markersSerum analyzerNo effectZande et al. ([@CR92])Plasma IgG and IgM and cytokine analysisELISANo effectLiverTranscriptomic analysismRNA quantification kitNo effectLiver, jejunum, kidneys and spleenHistopathologyH & E stainingPresence of fibrosis in the liver of NM 202 treated ratsLiver, spleen, lungs, brain and testisTissue distributionICP-MSNM 202 detected in lungs, kidneys and spleen; SAS only in the spleenPy-SiNPsIntravenous13 ± 5 nmVekton LtdRat; Wistar7 mg/kg bw7, 30 and 60 daysBloodHemodynamicsBlood pressure measurement and heart rateNo effectZhuravskii et al. ([@CR92])Blood cell countHematoanalyzerNo changeOrgan damage bio-markersSerum analyzerIncrease of ALP at 7 dLiver, heart, spleen, lungs and kidneysTissue distributionAtomic absorption spectrometrySi detected in liver, lungs and spleenNP localizationSEMNPs detected in hepatocytesHistopathologyH & E stainingInduction of fibrosisSiNPsOral gavage70 nm, 300 and 1000 nm with or without carboxyl or amine groupsMicromod PartikeltechnologieMice; BALB/c2.5 mg/mouseDaily for 28 daysBloodBlood cell countHematoanalyzerNo effectYoshida et al. ([@CR92])Organ damage bio-markersSerum analyzerNo effectAll major organsHistopathologyH & E stainingNo effectIntestineIntestinal absorptionEvented gut sac analysisAbsorption of coated 70 nm SiNPsSiNPsOral gavage10--15 nmTECNANRat; Wistar (male)333.3 mg/kg bwDaily for 5 daysAnimalClinical signsObservationSymptoms of vomiting and severe lethargyHassankhani et al. ([@CR41])BloodOrgan damage bio-markersSerum analyzerIncreaseKidneys, lungs and testisHistopathologyH & E stainingTissue damage observedSiNPsIntratrachealThree SiNPs (30, 60, and 90 nm) and one fine-sized silica (600 nm)Laboratory synthesisRat; Wistar (male)2,5 and 10 mg/kg bwDaily for 16 daysBlood and HeartBlood cell countHematoanalyzerIncrease of WBCs & platelets and decrease of hemoglobin &RBCsDu et al. ([@CR21])Oxidative stressLPO, GSH, SOD and GSH-Px assayIncrease of MDA formationOxidative stressNO/NOSIncrease of NO and decrease of NOSPro-Inflammatory response(s)ELISAIncrease of TNF-a, IL-1b and IL-6Tissue distributionICP-OESNPs detected in heartSiNPs in paintsOropharyngeal19 nmSiNPsMice; BALB/c mice20 µg/aspirationOnce a week for 5 wLungsInflammationBALF Cell countIncrease of macrophages and neutrophilsSmulders et al. ([@CR92])Pro-inflammatory response(s)ELISANo effectTissue distributionICP-MSNPs detected in lungsSiNPsIntranasal10 and 80 nm SiNPsNanoamorRat; Wistar (male)150 µg/50 µl PBS/ratDaily for 30 daysBrainOxidative stressLPO assayIncrease of MDA formationParveen et al. ([@CR86])Xylenol orange assayIncrease of H~2~O~2~ levelsGSH depletionIncreaseSOD, CAT and GPx levelsIncreasePro-Inflammatory response(s)RT-PCR and ELISAIncrease TNF-α, IL-1β and MCP-1Nuclear binding activityImmuno blot analysisIncreaseTissue distributionICP-OESSi detected in frontal cortex, corpus striatum and hippocampusSiNPsTopical70 nm, 300 and 1,000 nmMicromod PartikeltechnologieMice; BALB/c250 mg/earDaily for 28 daysSkinApoptosisTUNEL stainingIncreaseNabeshi et al. ([@CR74])AnimalTissue distributionIn vivo Imaging70 nm SiNPs detected around the liverIntravenous30 mg/kg bw24 hNP internalizationTEM70 nm SiNPs detected in cytoplasm and nucleus of the parenchymal hepatocytes (liver)SiNPsIntravenous15 nmSigma-AldrichRat; SD (male)50 mg/kg bw48 hBloodBlood cell countHematoanalyzerIncrease of WBC, lymphocytes, monocytes and neutrophilsChen et al. ([@CR7])LiverCD-68 positive cellsCD-68 stainingIncreaseOxidative stressGSH and SOD assayIncreaseInjury bio-markersProton-NMR spectroscopic analysisIncrease*JRC* Joint research commission, *TEM* Transmission electron microscopy, *WBCs* White blood cells, *ICP-MS* Inductively coupled plasma mass spectrometry, *H & E* Hematoxylin and eosin, *EDX* Energy dispersive X-ray spectroscopy, *ELISA* Enzyme linked immuno sorbent Assay, *CD* Cluster of differentiation, *ICP-OES* Inductively coupled plasma optical emission spectroscopy, *BALF* Bronchoalveolar lavage fluid, *VEGFR* Vascular endothelial growth factor receptor, *MMP* Mitochondrial membrane potential, *DAPI*-4′,6-diamidino-2-phenylindole, dilactate, *SEM* Scanning electron microscopy, *TUNEL* Terminal deoxynucleotidyl transferase dUTP nick end labeling, *NMR* Nuclear magnetic resonance

In vitro studies {#Sec6}
================

Cytotoxicity {#Sec7}
------------

Oxidative stress (over production of reactive oxygen species, i.e., ROS) induced by NPs could damage the cellular components and lead to cell death via apoptosis (Fu et al. [@CR31]). Therefore, studies reporting on cytotoxicity and oxidative stress were summarized in this section.

### Cytotoxicity associated with oxidative stress {#Sec8}

Duan et al. ([@CR22]) showed that S-SiNPs (62 nm) induced time- (6, 12, and 24 h) and dose-dependent (25--100 µg/ml) reduction in cell viability (assessed by 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide, i.e., MTT), loss of membrane integrity (lactate dehydrogenase (LDH) release) and apoptosis (Annexin V/PI staining) in human umbilical vein endothelial cells (HUVECs). Apoptosis was also induced in lung (A549) and skin epithelial cells (A431) treated with Pr-SiNPs (15 nm). A dose-dependent increase (25--200 µg/ml for 72 h) in cytotoxicity (MTT and LDH), ROS production (assessed by dichlorodihydrofluorescein assay, i.e., DCFH-DA), lipid peroxidation (measurement of malondialdehyde, i.e., MDA), and apoptosis (caspase 3 and 9 activity) was observed in both cell lines. The lung cells showed, in general, a slightly higher toxic response compared to skin cells (Ahamed [@CR1]).

SiNPs (20 and 80 nm) induced P53-mediated apoptosis in human fetal lung fibroblasts (HFL-1). At the dose of 500 µg/ml, 20 nm SiNPs induced a threefold increase in DCF fluorescence compared to 80 nm. In addition, increased expression of P53, upregulation of cytochrome C (CytC) and caspase 9, and downregulation of anti-apoptotic protein B-cell lymphoma 2 (bcl2) was observed in cells treated with 1000 µg/ml for 48 h (Xu et al. [@CR92]). Another study with lung fibroblasts also showed that SiNPs (20 nm) could reduce cell viability (MTT) by inducing apoptotic cell death (fluorescence microscopy) in a dose-dependent manner (250--1000 µg/ml for 48 h) (Zhang et al. [@CR92]). Athinarayanan et al. ([@CR4]) isolated SiNPs (10--50 nm) from commercial food products processed with food additive silica (E551) and exposed human lung fibroblasts (WI-38 cell line) with increasing doses (25--400 µg/ml). After 24 h, they observed cytotoxicity (MTT) in a dose-dependent manner and ROS production (DCFH-DA) at 50 µg/ml.

### Cytotoxicity not associated with oxidative stress {#Sec9}

Py-SiNPs (12 and 40 nm) induced a significant size and dose- (31.3, 93.8, and 156.3 µg/cm^2^ culture well) dependent cytotoxicity (LDH, Sulphorodhamine B assay (SRB) and water-soluble tetrazolium-1(WST-1)) in human colon carcinoma cell line (HT29), while no induction of ROS (DCFH-DA) was observed (Gehrke et al. [@CR32]). In the study by Napierska et al. ([@CR76]), 50 μg/ml (24 h) of 16 nm iron-doped S-SiNPs and pure S-SiNPs induced strong cytotoxicity (MTT and LDH) in a human endothelial cell line (EA.hy926), but a significant increase in oxidative stress markers \[GSH depletion, malondialdehyde (MDA formation), induction of heme oxygenase-1, glutathione reductase, and NADPH oxidase-1\] was observed only for iron-doped SiNPs.

### Conclusion: cytotoxicity {#Sec10}

Cytotoxicity of SiNPs was investigated using different cell lines and incubation times, making the comparison between studies difficult. However, from Table [3](#Tab3){ref-type="table"}, it is clear that all types of SiNPs induced cytotoxicity. Significant (compared to untreated cells) cytotoxic effects were observed only at or above the concentration of 25 µg/ml. Furthermore, it can be clearly seen that SiNPs induced oxidative stress and mediated apoptosis mainly via the *intrinsic or mitochondrial pathway* (caspase-dependent pathway) in a size- and dose-dependent manner. ROS-mediated toxicity is believed to be an important mechanism of NP toxicity including SiNPs (Manke et al. [@CR66]). Nevertheless, Py- and S-SiNPs caused cytotoxicity without measurable levels of ROS production. It was demonstrated that the *disturbance of membrane integrity* due to direct cell-membrane interaction might be another possible mechanism of NP cytotoxicity (Fröhlich et al. [@CR29]; Thomassen et al. [@CR92]). However, neither of these studies did substantiate these observations and, therefore, SiNPs cytotoxic effects in the absence of oxidative stress remain poorly understood.Table 3Comparison of toxic effects induced by different types of SiNPs (in vitro)SiNP typeCell typeCytotoxicityApoptosisGenotoxicityOxidative stressPro-inflammationReferencesColloidalCaco2✓✓✓✓✓Tarantini et al. ([@CR92], [@CR92])ColloidalHepG2✓✓✓✓n/aLi et al. ([@CR57])ColloidalV79 and A549✓n/a✓n/an/aMaser et al. ([@CR67])ColloidalJ744.1✓✓n/a✓✓Lee et al. ([@CR53])ColloidalPBMC✓✓n/a✓✓Mendoza et al. ([@CR70])StöberHuvecs✓✓✓✓✓Duan et al. ([@CR22])StöberHepG2✓✓n/a✓n/aSun et al. ([@CR97])StöberHepG2✓✓n/a✓n/aWang et al. ([@CR92])StöberHaCaT✓✓n/a✓n/aLiang et al. ([@CR59])StöberEA.hy926✓n/an/a✓n/aNapierska et al. ([@CR76], [@CR77])PrecipitatedV79✓✓✘✘n/aGuichard et al. ([@CR36])PrecipitatedMouse fibroblast✓n/a✘n/an/aUboldi et al. ([@CR92])PrecipitatedGES-1 and caco2✓✓n/a✓n/aYang et al. ([@CR92], [@CR92])PrecipitatedHepG2✓✓n/a✓n/aAhmad et al. ([@CR2])PrecipitatedA549 and A431✓✓n/a✓n/aAhamed ([@CR1])PrecipitatedM-HS✓n/an/a✘✓Di Cristo et al. ([@CR18])PrecipitatedRAW.264.7✓n/an/a✘✓Di Cristo et al. ([@CR18])PyrogenicV79✓✓✓✘n/aGuichard et al. ([@CR36])PyrogenicGES-1 and caco2✓✓n/a✘n/aYang et al. ([@CR92], [@CR92])PyrogenicHT-9✓n/an/a✘n/aGehrke et al. ([@CR32])PyrogenicRAW.264.7✓n/an/a✘✓Di Cristo et al. ([@CR18])PyrogenicM-HS✓n/an/a✓✓Di Cristo et al. ([@CR18])n/a, not investigated; ✓, positive; ✘, negative

Furthermore, some authors used very high concentrations that may cause "overloading" of cells and modify the nature of NP--cell interactions (Wittmaack [@CR92]). In these cases, it is difficult to evaluate whether the observed effects are physiologically relevant. Although it is challenging, we consider a dose of 384 µg/cm^2^ or higher as irrelevant to human inhalation exposure for amorphous silica, based on the estimation that can be derived from the occupational exposure levels (OELs) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2In vitro dose estimation from human tolerable levels (OELs)

Genotoxicity {#Sec11}
------------

In this section, we presented studies on genotoxic effects of SiNPs as it is used as another major endpoint to characterize hazard of NMs. Direct interaction with DNA, oxidative DNA damage, depletion of anti-oxidants, cell cycle arrest, and abnormal expression of genes have been identified as potential mechanisms of NP mediated (geno)toxicity (Donaldson et al. [@CR19]).

### DNA damage associated with oxidative stress {#Sec12}

Exposure to SiNPs (15, 30, and 100 nm) resulted in a size- and dose- (2.5--10 µg/ml for 24 h) dependent increase in 8-hydroxy-2′-deoxyguanosine levels (8-OH-dG), phosphorylation of histone on serine-139 (ɣH2AX), and DNA strand breaks (comet) in human keratinocytes (HaCaT) (Gong et al. [@CR35]). Nabeshi et al. ([@CR73]) also demostrated that exposure to SiNPs (70 nm; 10--90 µg/ml for 24 h) resulted in the increase of oxidative DNA damage (8-OH-dG levels) in HaCaT cells. SiNPs were taken up via actin-mediated endocytosis. Micron-sized particles used in these studies showed no or little effects.

The viability of human Caucasian colon adenocarcinoma (Caco-2) cells dropped to 40% when exposed to 15 nm C-SiNPs (64 µg/ml for 24 h), and, at this same concentration, nearly a threefold increase in micronuclei formation, fivefold increase in histone phosphorylation (ɣH2AX), and a significant increase in DCF fluorescence were observed. The particles were localized within lysosomes and endocytic compartments, but not in the nucleus. 55 nm C-SiNPs did not induce any of these effects at the same concentration (Tarantini et al. [@CR92]).

A non-significant increase in % tail DNA (comet assay) and no chromosomal aberrations were induced by 17 nm SiNPs in human peripheral lymphocytes treated with 100 µg/ml, while a dose-dependent (50--100 µg/ml for 24 h) ROS production (DCFH-DA) and GSH depletion were observed (Rajiv et al. [@CR91]).

### Cell cycle arrest associated with oxidative stress {#Sec13}

S-SiNPs (62 nm) induced increase in DCF fluorescence and decrease in superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in HUVECs in a dose-dependent manner (25--100 µg/ml for 24 h). Oxidative stress was linked to cell cycle arrest at G2/M checkpoint (upregulation of chk 1 and downregulation of Cdc25c, Cyclin B1, and Cdc2) and increase in apoptosis (Duan et al. [@CR22]). In the study by Li et al. ([@CR57]), a size-dependent (19, 43, and 68 nm) increase in oxidative stress (DCF fluorescence) and cell cycle arrest in S and G2/M was observed in HepG2 cells exposed to 100 µg/ml of C-SiNPs. Cell cycle arrest in G2/M phase along with the increase in ROS was also noticed in human hepatic cell line (LC-02) treated with S-SiNPs (50 nm) in a dose-dependent manner (50--200 µg/ml for 24 h) (Wang et al. [@CR92]).

### DNA damage not associated with oxidative stress {#Sec14}

Genotoxicity of Py-SNP (20 and 25--70 nm), Pr-SNP (20 nm), and C-SNP (15 and 40--80 nm) SiNPs were studied in Chinese hamster lung fibroblasts. Py-SiNPs (20 nm) induced a significant increase in DNA strand breaks at 66 µg/ml (24 h), while C-SiNPs (15 nm) showed a similar effect only at 252 µg/ml. Neither of these SiNPs did induce ROS. SiNPs in the size range 25--80 nm exerted no or little genotoxicity (Guichard et al. [@CR36]).

### Genotoxicity reports without the assessment of oxidative stress {#Sec15}

M-SiNPs (100 nm) induced a significant increase in phosphorylated-ɣH2AX-foci in HT-29 cells treated with a dose of 10 µg/ml for 24 h (Sergent et al. [@CR92]). In the human embryonic kidney cell line (HEK293), 579 genes were upregulated and 1263 genes were downregulated after 24 h of exposure (100 µg/ml) to 100 nm M-SiNPs (Zhang et al. [@CR92]). In another study, 15-nm C-SiNPs induced a significant increase in DNA strand breaks (comet assay) in chinese hamster cells (V79) and A549 cells at 100 µg/ml (24 h), but, for 55 nm, this effect was observed only in A549 cells (Maser et al. [@CR67]). A significant increase in DNA tail length (comet assay) was observed in HaCaT cells treated with 30 µg/ml (24 h) of 70 nm SiNPs (Nabeshi et al. [@CR74]).

Exposure to C-SiNPs (\~7 nm) resulted in positive genotoxic effects (Lymphoma assay) in mouse lymphoma cells treated with 100 and 150 µg/ml for 4 h (Demir and Castranova [@CR17]). SiNPs (12 nm) induced DNA strand breaks in RAW 264.7 at 200 and 400 µg/ml, but the induction of micronuclei was noticed only at 400 µg/ml. The particles were internalized in vesicles and in the nucleus (Hashimoto and Imazato [@CR40]).

At any tested concentrations (1--100 µg/ml for 72 h), SiNPs (10--25, 5--30, 35, 15, 80, and 90 nm) neither induced cytotoxicity nor micronuclei in immortalized Balb/3T3 fibroblasts (Uboldi et al. [@CR92]). In another study, Pr-SiNPs (NM-200 and NM-201) and Py-SiNPs (NM-202 and NM-203) with primary size between 14.5 and 16 nm did not induce any micronuclei (cytokinesis block micronucleus assay) in human peripheral lymphocytes exposed to different concentrations (200--1250 µg/ml) over 24 h (Tavares et al. [@CR99]). It is also worthy to note that, in the latter study, the positive control used did not differ from control conditions.

### Conclusion: genotoxicity {#Sec16}

C-SiNPs and S-SiNPs induced genotoxicity in human tumor cell lines (lung, kidney, skin, and gastro-intestinal systems) and the amplitude of the effect negatively correlated with the size of the NPs. DNA strand breaks were observed at low concentrations (2.5--10 µg/ml), particularly in skin-derived cell lines. The genotoxic effects of C- and S-SiNPs were mainly associated with the induction of oxidative stress, while such information is very limited for other types (Py- and Pr-SiNPs). One study indicated that Py-SiNPs induce DNA damage without the generation of ROS, suggesting that other mechanisms such as direct DNA damage might be involved (Magdolenova et al. [@CR65]). However, it is very difficult to judge whether such genotoxic effect is direct or indirect, since the cellular uptake and subcellular localization of SiNPs are not often reported. Furthermore, several factors such as SiNP properties, cell type, and exposure scenarios (such as concentrations, assays, and endpoints) may influence the outcomes (Magdolenova et al. [@CR65]), making the comparison difficult between studies and indicating an urgent need for the standardization of genotoxicity studies.

Immunotoxicity {#Sec17}
--------------

NPs entering the body will most probably interact with immune cells, as they are the first line of defence in human body. In this section, we presented the immune responses induced by SiNPs in different cell lines.

### Immunotoxicity associated with oxidative stress {#Sec18}

Hara et al. ([@CR39]) exposed THP-1-derived macrophages to 100 µg/ml of SiNPs (30 nm) for 6 h and found a significant increase in interleukin-1-beta (IL-1β), ROS production, and SiNP uptake via phagocytosis. In the study of Choi et al. ([@CR200]), larger sized SiNPs (150--200 nm) were effectively phagocytosed by primary rat microglial cells after 24 h of exposure to different concentrations (0.0728--7.28 µg/ml). A significant increase in ROS, reactive nitrogen species (RNS) and IL-1β was detected at all concentrations.

### Immunotoxicity not associated with oxidative stress {#Sec19}

At 10 and 20 µg/ml, Di Cristo et al. ([@CR18]) found that Py-SiNPs (\~14 nm) induced a stronger increase of tumor necrosis factor-alpha (TNF-α), interleukin(IL)-6, and IL-1β in RAW.264.7 macrophages compared to similar sized Pr-SiNPs; Notably, no SiNPs induced ROS in RAW.264.7 macrophages.

### Immunotoxicity reports without the assessment of oxidative stress {#Sec20}

A significant increase in TNF-α, IL-6, and IL-1α, mitogen activated protein kinases (MAPKs), and nuclear factor (NF)-κB were observed only for C-SiNPs (100 nm) in J774A.1 macrophages exposed to 100 µg/ml of same sized (100 nm) C-SiNPs or M-SiNPs (Lee et al. [@CR53]).

Uemura et al. ([@CR92]) showed that SiNPs (10 and 50 nm) caused dose-dependent (6.25--100 µg/ml) increase in the production of TNF-α and decrease of IL-6 in RAW.264.7 macrophages, while their amine surface-modified counterparts did not. Furthermore, 300 and 1000 nm micron-sized particles (both bare and amine modified) also showed a dose-dependent decrease of IL-6. Notably, the effects were stronger for 50 nm compared to other particles. The same cell line was utilized by Yu et al. ([@CR92]) to investigate phagocytosis using inductively coupled plasma mass spectroscopy (ICP-MS), and they found that S-SiNPs (25 nm) were phagocytosed at least ten times more than M-SiNPs of same size and high aspect ratio SiNPs (AR 2, 4, and 8). In the study by Napierska et al. ([@CR77]), THP-1 cells dosed with 5 µg/cm^2^ S-SiNPs (2 nm) showed a significant increase of IL-8, TNF-α, and macrophage inflammatory protein (MIP)-1α, while only a non-significant increase in MIP-1α expression was observed for 16 and 104 nm S-SiNPs.

### Conclusion: immunotoxicity {#Sec21}

The main cells used to study immune responses to SiNPs were 'innate' cells such as monocytes and macrophages. Therefore, the identified in vitro studies only address a very limited part of the immune system, essentially pro-inflammatory responses and potential phagocytosis. Furthermore, the data on immune responses and oxidative stress are very limited and, therefore, no firm conclusions can be made. SiNPs, not only induced stronger pro-inflammatory responses compared to sub-micron and micron sized particles but also size-specific effects within the nano-range in immune cells are observed. Besides size, shape and porosity seem to influence the phagocytosis of SiNPs.

Autophagy {#Sec22}
---------

Recently, a growing body of evidence identified autophagy as a cellular defence mechanism against NP toxicity, since it plays a key role in removing misfolded proteins and clearing damaged organelles (Glick et al. [@CR34]). Hence, we present here studies that show induction of autophagy upon exposure to SiNPs.

### Autophagy associated with oxidative stress {#Sec23}

The same S-SiNPs (62 nm) were used in three studies to investigate the induction of autophagy. Along with the dose-dependent (25--100 µg/ml) increase in ROS production, increase in autophagy bio-marker-microtubule-associated protein 1A/1B-light chain 3 (LC3) and monodansylcadaverine (MDC) labelled autophagic vacuoles were detected in HepG2 cells treated with 62 nm S-SiNPs. In addition, transmission electron microscopy (TEM) images revealed that autophagosomes and autolysosomes induced in the presence of SiNPs (Yu et al. [@CR92]). The same S-SiNPs (62 nm) induced increase of LC3-II/LC3-I ratio and decrease of p-mTOR/mTOR, p-P13 K/P13 K and p-Akt/Akt in HUVEC cells in a dose-dependent (25--100 µg/ml) manner (Duan et al. [@CR23], [@CR24], [@CR25]). The results of Guo et al. ([@CR38]) also suggest that 50 µg/ml of S-SiNPs (58 nm) could induce autophagy via MAPK/Bcl-2 and PI3K/Akt/mTOR signaling in HUVECs.

After 4 h of exposure to 200 µg/ml of S-SiNPs (50 nm), autophagosomes and ROS production was observed in HaCaT cells. The TEM images revealed that SiNPs were in the cytoplasm and lysosomes, but not in the nucleus. (Liang et al. [@CR59]).

SiNPs (4--13 nm, 62.5 µg/ml) induced a time-dependent (24, 48, and 72 h) reduction in cell viability and increase in oxidative stress (DCF fluorescence and GSH depletion) in the lung fibroblast cell line MRC-5. Compared to control, a significant increase of autophagic vacuoles and LC-3 II/LC3-I ratio was also observed in a time-dependent manner (Voicu et al. [@CR92]). A549 cells, when exposed to 100 and 1000 µg/ml of 20-nm SiNPs, showed threefold and fivefold increase in MDC fluorescence, respectively. In addition, autophagy genes such as ATG-12 and BECN were significantly upregulated (30- and 50-fold, respectively) along with increased production of ROS in cells dosed with 1000 µg/ml (Nowak et al. [@CR80]).

### Conclusion: autophagy {#Sec24}

SiNPs, particularly S-SiNPs induced autophagy mainly via oxidative stress-mediated upregulation of autophagy-related genes and differential regulation of Akt/mTOR signaling. Similar to cytotoxicity, 25 µg/ml appeared to be the lowest exposure concentration at which SiNPs exhibited significant effects. Furthermore, induced autophagy is correlated to cytotoxicity, suggesting that exposure to SiNPs caused irreversible (serious) cellular damage and resulted in autophagic cell death. Besides autophagy induction, lysosomal and autophagy dysfunction could be a potential mechanism of NPs toxicity (Stern et al. [@CR92]), which has, however, not been investigated for SiNPs.

Toxic effects on blood cells and endothelial dysfunction {#Sec25}
--------------------------------------------------------

Several studies suggest that NPs, when inhaled or ingested, can translocate across barriers (such as air--blood) of the body, enter the circulation, and interact with the cardiovascular system. In this section, we summarized the studies that report the effects of SiNPs on blood and endothelial cells.

### Toxic effects on blood cells {#Sec26}

Nemmar et al. ([@CR78]) showed that mouse blood platelets could aggregate after 3 min of incubation with 5 or 25 µg/ml of 50-nm C-SiNPs, while in the study of Jose Corbalan et al. ([@CR45]), such aggregation was observed in 15 min (10 µg/ml of 10 nm C-SiNPs). The latter study also showed fourfold reduction of the nitric oxide (NO)/peroxynitrite (ONOO^−^) ratio compared to non-treated platelets.

Maurer-jones et al. ([@CR68]) investigated the role of porosity of SiNPs on blood cell toxicity. M-SiNPs (25 nm) reduced the cell viability of red blood cells (RBCs) to 50% at the concentration of 270 µg/ml, while non-porous S-SiNPs of similar size required only 20 µg/ml to reach this level of cytotoxicity. In another study, 10% hemolysis (LC~10~) of RBCs was observed at 36 µg/ml for S-SiNPs (115 nm), while M-SiNPs required 154 µg/ml to induce the same effects. For amine-coated counterparts, LC~10~ were 97 and 30 µg/ml for S- and M-SiNPs, respectively (Yu et al. [@CR92]).

### Endothelium dysfunction {#Sec27}

Exposure to different concentrations (12.5--100 µg/ml) of S-SiNPs (58 nm) resulted in a dose-dependent increase in inflammatory mediators such as IL-1β, IL-8, and TNFα, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1) in HUVEC cells (Guo et al. [@CR37]). In the study of Corbalan et al. ([@CR11]), 10 µg/ml of 10-nm C-SiNPs induced extremely low NO/NOO^−^ ratio (\~0.1) in HUVEC cells. Furthermore, free radical production, pro-inflammatory cytokines (IL-6 and IL-8), and NF-κB-binding activity were significantly increased in treated cells. In these two studies, increase in ROS was observed at all tested concentrations.

S-SiNPs (62 nm) induced an imbalance in the ratio NO/nitric oxide synthase (NOS) enzyme in HUVEC cells and such imbalance resulted in a significant increase of pro-inflammatory response (c-reactive protein CRP, IL-1β, IL-6, and TNFα) in a dose- (50--100 µg/ml) dependent manner (Duan et al. [@CR25]).

### Conclusion: Toxic effects on blood cells and endothelial dysfunction {#Sec28}

Endothelial cells and platelets together play a key role in maintaining the vascular homeostasis (Rajendran et al. [@CR90]). C-SiNPs induced oxidative stress and disturbed NO/NOO^−^ ratio, which resulted in the aggregation of platelets and endothelial dysfunction. This information is not available for other types of SiNPs. Furthermore, C-SiNPs mediated endothelial dysfunction resulted in pro-inflammatory signals via the secretion of cytokines and adhesion molecules. Together, these results suggest the potential of SiNPs to cause vascular thrombosis and atherosclerosis (Radomski et al. [@CR89]). Furthermore, SiNPs caused hemolysis of RBCs in a size-, charge-, and porosity-dependent manner.

Neurotoxicity {#Sec29}
-------------

NPs of very small size are capable of translocating across the blood--brain barrier (Hu and Gao [@CR43]). Therefore, studies investigating effects on cells relevant for neurotoxicity are presented here.

Rat medulla tumor cells (PC12 cell line) incubated with the supernatant of 20 nm SiNPs-treated-microglial cells (250 µg/ml and 500 µg/ml for 24 h) did not show any effects compared to the control. Earlier in this study, no secretion of bio-mediators was observed in SiNPs-treated-microglial cells (Xue et al. [@CR92]). In contrast to this study, PC12 cells exposed directly to SiNPs (25 nm; 25--200 µg/ml for 24 h) showed increased uptake and a dose-dependent increase in the induction of autophagy (increase in LC-II and Beclin 1) and inhibition of PI3 K-Akt-mTOR signaling (Xie and Wu [@CR92]). Yang et al. ([@CR92]) showed that exposure to SiNPs (15 nm; 10 µg/ml for 24 h) induced pathological signs of Alzheimer's disease such as altered expression of amyloid precursor protein (APP) and neprilysin, enhanced phosphorylation of tau at Ser262 and Ser396, and activation of glycogen syntheses kinase (GSK)-3β in human SK-N-SH and mouse neuro2a neuroblastoma cells.

### Conclusion: neurotoxicity {#Sec30}

In vitro studies used cell lines of CNS-based cells, mainly neuron like cells. Although the data on the neurotoxic effects of SiNPs are very limited, studies above suggest that SiNPs can induce adverse effects including the markers of Alzheimer's disease, when in direct contact with neuroblastoma cells.

Miscellaneous issues {#Sec31}
--------------------

### Influence of cell lines on SiNPs cytotoxicity {#Sec32}

A dose- (80--640 µg/ml) dependent decrease in the viability and increase of apoptosis were observed in HepG2 cells in presence of SiNPs (7 and 20 nm), but a significant reduction was observed in normal human liver cells (LC-02) only at the unrealistic dose level of 640 µg/ml (Lu et al. [@CR63]). In another study, SiNPs (10--50 nm) induced a dose-dependent (100--600 µg/ml) increase in LDH release in Caco-2 cells, but a significant release of LDH was observed only at the unrealistic dose of 600 µg/ml in human gastric epithelial cells (GES-1). Furthermore, exposure to these SiNPs (200 µg/ml for 48 h) also induced cell cycle arrest in S phase for GES cells and G2/M in Caco-2 cells (Yang et al. [@CR92]). In a porcine kidney cell line (LLC PK1) exposed to 20-nm SiNPs, a dose- (5--50 µg/ml) dependent increase in DCF fluorescence and MDA formation was observed, whereas human kidney cells (HK-2) showed little effects at 50 µg/ml (Passagne et al. [@CR87]).

### Conclusion: miscellaneous issues {#Sec33}

No firm conclusions can be drawn from these cases; however, the cytotoxicity of SiNPs appears to vary with species and cell line.

### Physiologically relevant cultures {#Sec34}

#### Lung co-culture models {#Sec35}

Co-cultures of lung cells are usually made with epithelial cells on the apical and endothelial cells on the basal compartment of a transwell membrane, with or without monocytes on top of the epithelial cells. In a co-culture (A 549 at the apical and ISO-HAS-1 at the basolateral compartment) exposed to 100-µg/ml 30-nm C-SiNPs (coated with or without surfactant), nearly a fivefold increase of IL-8 release for both forms of SiNPs was observed in both compartments (Kasper et al. [@CR48]). When other epithelial cells were used---H441 cells---at the apical together with ISO-HAS-1 cells at the basolateral compartment, these C-SiNPs induced IL-8 were expressed in both compartments, while SiCAM-1 (6--600 µg/ml) and IL-6 (at 6 and 60 µg/ml) were observed only in the apical part (Kasper et al. [@CR47]). The same co-culture model was exposed to 100 µg/ml of S-SiNPs (15, 35, and 80 nm) and the authors noticed an increase of IL-8, TNF-α, and surfactant protein (SP-A1 and SP-A2) expression compared to the control. In addition, less IL-8 and surfactant protein expression, and more TNF-α were observed in the co-culture added with THP-1, notably the effect was the highest for 35 nm (Farcal et al. [@CR27]).

Napierska et al. ([@CR77]) tested SiNPs with primary size 2, 16, 60, and 104 nm (dosed at 10 µg/cm^2^) in a co-culture (A549 at the apical and EA. hy926 at the basolateral compartment) and observed increase in cytokines such as IL-6, IL-8, TNF-α, and MIP-1α only for 60 and 2 nm (except IL-8). When THP-1 were added to the co-culture, a significant increase in IL-8 and decrease in TNF-α were observed only for 2 nm. The expression of cytokines was also differentially regulated for 16 and 104 nm before and after THP-1 added, but the effects were stronger for 60 and 2 nm, particularly 60-nm NPs.

#### Air--liquid interface {#Sec36}

At the air--liquid interface (ALI), aerosolized and deposited 12-nm Py-SiNPs (52 µg/cm^2)^ and 50-nm S-SiNPs (117 µg/cm^2^) induced significantly less biological effects (LDH leakage, IL-8 release, COX-2 expression, and p38 phosphorylation) in A549 cells compared to A549 exposed to 15.6 µg/cm^2^ under sub-merged conditions (Panas et al. [@CR85]).

### Conclusion: physiologically relevant cultures {#Sec37}

Sub-merged (co) cultures and ALI systems (Lenz et al. [@CR55]; Panas et al. [@CR85]) have been claimed to more closely mimicking the in vivo exposure scenarios compared to monocultures. In these systems, the toxicity and pro-inflammatory responses are significantly modulated by SiNPs, which represent the complexity of in vivo systems and need for the establishment of physiologically relevant in vitro cultures. However, at this moment, it is difficult to know whether these biological responses were influenced by SiNPs physico-chemical properties.

### Chronic in vitro studies {#Sec38}

In vitro chronic Py-SiNPs (12 nm) exposure of intestinal epithelial cell line (C2BBe1) was examined in a recent study. The cells were exposed to 10-µg/cm^2^ SiNPs for 24 h. After 24 h, the medium was replaced (without NPs) and cells were allowed to grow for 4--6 days. At the end of incubation, cells were passaged and again exposed for 24 h and grown for 4--6 days; this cycle was repeated for 29 passages (total life span). The cells and supernatants were collected at the end of each passage for analysis. Though the particles were internalized (only in a fraction of cells), no significant induction of necrosis, apoptosis, and LDH release and decrease in cell viability was observed for any of these conditions (McCracken et al. [@CR69]).

In vivo studies {#Sec39}
===============

Ingestion exposure {#Sec40}
------------------

### Single exposure {#Sec41}

Lee et al. ([@CR54]) investigated the tissue distribution and excretion profiles in Sprague--Dawley (SD) rats orally administered with a very high dose of 500 or 1000-mg/kg bw of C-SiNPs (20 and 100 nm). Silicon (Si) levels were significantly elevated in liver, kidney, lung, and spleen at 6-h post-administration, while no such increase was noticed in brain, ovaries or testes, esophagus, stomach, and intestine even after 7 days of post-administration. Nearly 75--80% of administered SiNPs were excreted via urine and 7--8% via feces. The author also noticed that 20 nm SiNPs excreted faster than the 100 nm SiNPs. In another study, C-SiNPs (12 nm) did not induce any toxicity after 14 days in SD-rats administered with a single oral dose (1959 or 2061 mg/kg bw) (Yun et al. [@CR92]).

In the study of Li et al. ([@CR58]), M-SiNPs with different aspect ratios (AR, spherical 83 nm with AR 1, short rods with AR 1.75 and long rods with AR 5) were administered in mice (40 mg/kg bw via gavage). After 7 days, a very high amount of Si was detected only in the liver of spherical SiNPs exposed mice. Urinary excretion, intestinal absorption, and organ distribution of SiNPs were decreased with increasing aspect ratio. Furthermore, increase in renal damage such as hemorrhage, vascular congestion, and renal tubular necrosis with increasing aspect ratio was observed after 14 days of administration.

Kim et al. ([@CR51]) exposed C57BL/6 mice (oral gavage; 750 mg/kg bw) to C-SiNPs (20 and 100 nm) that had been modified with or without [l]{.smallcaps}-arginine to determine the influence of surface charge on immunotoxicity in vivo. After 14 days, the author noticed a size-dependent decrease in WBCs cell count and cytokines (in blood), and reduced proliferation of B cells and T cells (from spleen) only for uncoated SiNPs.

### Repeated exposure {#Sec42}

C-SiNPs (12 nm) neither induce abnormal changes in blood biochemical and hematological parameters nor accumulated in any organs of the acutely (489.8, 979.5, or 1959 mg/kg bw/day, during 14 days) or sub-chronically (244.9, 489.8, or 975.9 mg/kg bw/day, during 13 weeks) exposed (via gavage) SD rats (Yun et al. [@CR92]). In the study by Kim et al. ([@CR52]), C-SiNPs (20 and 100 nm) did not induce any significant changes (compared to control) in clinical signs, blood biochemical, hematological, and histopathological analysis in sub-chronically exposed Crl: CD (SD) specific pathogen-free rats (500, 1000, or 2000 mg/kg bw/day for 90 days).

SD rats were administered (via oral gavage) with low doses (5, 10 or 20 mg/kgbw) of Pr-SiNPs (NM 200 and 201) and Py-SiNPs (NM 202 and 203) at 0, 24 and 45 h and sacrificed at 3 h after the last administration. No significant genotoxicity was observed in cells extracted from different organs (duodenum, colon, blood, kidney, liver, and spleen), and no pathological conditions were recorded in any of these organs (Tarantini et al. [@CR92]).

Hofmann et al. ([@CR201]) investigated the prenatal toxicity by exposing pregnant Wistar rats to Pr-SiNPs (NM 200) from gestation day 6--19. At doses of 100, 300, or 1000 mg/kgbw/day, administered SiNPs did not induce malformations in fetuses or death of the rats.

Zande et al. ([@CR92]) investigated the sub-acute and sub-chronic toxicity of Py-SiNPs (7 nm) and NM-202 (10--25 nm). In the sub-acute part, male SD rats were orally (via food) exposed to 100, 1000, or 2500 mg Py-SiNPs/kg bw/day for 28 days, while in the sub-chronic part, the rats were exposed only to the highest dose (2500 mg/kg bw/day) repeatedly for 84 days. ICP-MS analysis of target organs showed that NM-202 was significantly distributed in the lung, kidney, and spleen. Although no Si was detected in the liver, histopathological analysis and gene expression studies revealed that fibrosis was induced in the liver after 84 days of exposure. Si was found in the spleen of Py-SiNPs exposed rats only at the end of chronic exposure. The examined parameters such as blood biochemistry, antibody levels (IgG and IgM), and cytokines indicated no systemic toxicity in any of the Py- or NM-202 treated rats.

Yoshida et al. ([@CR92]) found an increased intestinal absorption of carboxyl (twofold) and amine-coated SiNPs (1.5-fold) compared to uncoated SiNPs (70 nm) in orally exposed BALB/c mice (2.5 mg/mouse/day for 28 days). In this study, the whole small intestine was processed using the everted gut sac method and a significant amount of Si was detected by ICP-MS. However, no signs of systemic toxicity were observed for any of these SiNPs.

In male Wistar rats that exposed to 10--15 nm SiNPs (oral gavage; 333.3 mg/kg bw/day for 5 days), histopathological analysis revealed gross tissue damage in kidney (cell swelling and necrosis), lung (interstitial pneumonia and bronchopneumonia), and in the testis (congestion, reduction of spermatogenesis and edema). In addition, blood biochemical parameters such as albumin, cholesterol, triglycerides, total proteins, urea, high-density lipoprotein (HDL), and low-density lipoprotein (LDL), as well as alkaline phosphatase (ALP) and aspartate aminotransferase (AST) activities were significantly increased in treated mice (Hassankhani et al. [@CR41]).

Inhalation exposure {#Sec43}
-------------------

### Single exposure {#Sec44}

In the study of Morris et al. ([@CR72]), C57BL/6 mice were intratracheally instilled with 4- or 20-mg S-SiNPs/kg bw and significant effects were observed only at the dose of 20 mg/kg. Twenty hours after instillation, approximately 20- and 10-fold higher cell number was observed in the bronchoalveolar lavage (BAL) of mice treated with the bare and amine-coated SiNPs, respectively, compared to control mice; neutrophils were also increased about 30- and 20-fold, respectively.

In another study, 15- and 55-nm C-SiNPs neither induced DNA damage nor micronuclei in lung and bone marrow (erythrocytes) cells of Wistar rats at 72 h of post-instillation (360 µg) (Maser et al. [@CR67]). However, the distribution of administered SiNPs to these organs was not investigated.

### Repeated exposure {#Sec45}

A size- and dose-dependent increase in the distribution of SiNPs was observed in the serum and heart of male Wistar rats intratracheally instilled (2, 5, or 10 mg/kg bw/day for 16 days) with SiNPs (30, 60, 90, and 300 nm). Blood parameters (WBCs and platelets), inflammatory bio-markers (TNF-α, IL-1β, and IL-6), and oxidative stress bio-markers (ROS and MDA formation) were significant increased, while NO, NOS, and eNOS were significantly decreased in the serum of the treated mice (Du et al. [@CR21]).

A study compared the toxicity and biodistribution of pristine SiNPs (19 nm) and aged paints containing SiNPs in BALB/c mice. The suspensions (20 µg/aspiration) were oropharyngeally aspirated once a week for 5 weeks, and mice were sacrificed either at 2- or at 28-day post-final aspiration treatment. Pristine SiNPs were significantly distributed in the lungs and liver, while only a low amount of Si was detected in the liver of paint-exposed mice. No signs of toxicity were observed, except a slight inflammation (a slight increase in macrophages and neutrophils together with an increase of IL-1β) with pristine SiNPs (Smulders et al. [@CR92]).

Male Wistar rats were intranasally instilled with 150 µg SiNPs (10 and 80 nm) repeatedly for 30 days. After 30 days, a size-dependent increase in the levels of hydrogen peroxide (H~2~O~2~), MDA formation, TNF-α, IL-1β, MCP-1, and NF-ĸβ was observed in the frontal cortex, corpus striatum, and hippocampus of the brain. A similar quantity of Si was detected in all these three regions. In addition, a significant decrease in GSH levels was observed in these tissues (Parveen et al. [@CR86]). The latter study shows the potential translocation of (mainly small) SiNP from the nose to the brain, but it has to be noted that the mice received a high dose during 30 days.

Intratracheally administered (2 mg/kg bw; 15 times, once every 3 days) S-SiNPs (58 nm) resulted in reproductive toxicity in C57 mice via enhanced ROS production and cell cycle arrest (G0/G1 phase) in the testicular tissues, and by decreasing the number of mature sperms and primary spermatocytes (Zhang et al. [@CR92]). In another study, repeated intracheal instillation of S-SiNPs (58 nm; 0, 7, 21, and 35 mg/kg bw; 5 times, once every 3 days) induced local (macrophage activation in lung, liver, and spleen) and systemic inflammation (Increase in serum IL-8, TNF-α, and IL-6) in BALB/c mice. In addition, SiNPs were also detected in the lysosomes of macrophages in lung, liver, and heart tissues (Yang et al. [@CR92]).

Dermal exposure {#Sec46}
---------------

### Repeated exposure {#Sec47}

The skin of SD rats was repeatedly exposed to different doses (500, 1000 mg, or 2000 mg/kg bw) of [l]{.smallcaps}-arginine coated C-SiNPs (20 nm) for 90 days (6-h exposure/day). The repeated exposure neither induced gross changes in the skin nor in any organs. In addition, hematological and blood biochemical parameters did not change in SiNPs-treated mice compared to controls (Ryu et al. [@CR92]). In another study, Shim et al. ([@CR92]) showed that C-SINPS (20 and 100 nm) did not induce toxicity in the right and left brain or distribution in the cerebellum, hippocampus, or striatum of the dermally exposed rats (1000 or 2000 mg/kgbw daily for 90 days). In contrast to these studies, a significant increase in apoptosis (TUNEL positive cells) was observed in the skin of the BALB/c mice topically exposed to 70-nm SiNPs (250 mg/ear/day for 28 days). The author reported that the SiNPs were found not only in the skin but also in the regional lymph nodes, cerebral cortex, hippocampus, and in the liver (Nabeshi et al. [@CR74]).

Parenteral exposure {#Sec48}
-------------------

### Single exposure {#Sec49}

In a 48-h study, exposure to 15-nm SiNPs (dose of 50 mg/kg bw by intravenous injection) resulted in a significant increase of CD68-positive Kupffer cells (KCs), WBCs, lymphocytes, monocytes, neutrophils, and TNF-α in the serum of male SD rats. There was a decrease in GSH activity and elevation in MDA levels in the liver of treated mice. Furthermore, bio-markers of liver dysfunction such as lactate, phosphorylcholine, sn-glycero-3-phosphocholine, tyrosine, phenylalanine, and lysine were increased in blood, while the levels of succinate, glucose, and glycine were significantly decreased in mice exposed to SiNPs (Chen et al. [@CR7]).

In another study, 50 nm C-SiNPs (0.25 mg/kg bw) induced a significant increase in blood parameters such as leukocyte number, creatinine kinase (CK), ALT, AST, and LDH release in male tuck ordinary mice at 24-h post-intraperitoneal injection. Oxidative stress bio-markers such as MDA formation, SOD, and catalase were significantly increased in the lungs, liver, kidney, and brain of SiNPs-treated mice. Cytokines such as IL-6, IL-1β, and TNF-α were significantly increased in the lung and differentially expressed in other organs. Furthermore, all organs showed a significant DNA damage compared to saline treated mice and the extent of damage was in the order heart \> kidney \> lung \> liver \> brain (Nemmar et al. [@CR79]).

In the study of Duan et al. ([@CR24], [@CR25]), ICR mice were intravenously injected with 29.5, 103.5, or 177.5 mg/kg bw of 62 nm S-SiNPs. After 14 days, induction of autophagic vacuoles and mitochondrial rupturing in the heart tissues was observed using TEM. In addition, increase in LC3 positive staining in the heart tissues was detected at 103.5 and 177.5 mg/kg bw, and the expression of ICAM-1 and VCAM-1 was significantly decreased at 177.5 mg/kg. Huang et al. ([@CR44]) injected the mice intravenously with mesoporous rods (pure or PEGylated) at a dose of 20 mg/kg bw and found a dysfunction in biliary excretion and glomerular filtration. Blood analysis showed that there was a significant increase in total bilirubin (TBIL), blood urea nitrogen (BUN), and creatinine (CREA). The mesoporous rods mainly distributed in the lung, liver, and spleen, but PEGylation significantly reduced their distribution in these organs. In addition, short rods cleared via urine and feces more rapidly than long rods.

Yu et al. ([@CR92]) estimated the i.v. median lethal dose (LD~50~) for 64 nm C-SiNPs as 262 mg/kg bw in ICR mice using the Dixon's Up and Down method. After 14-day post-administration, intravenously injected C-SiNPs (64 nm, 177.5 mg/kg bw) induced a significant increase in liver injury bio-markers (LDH, AST, and ALT). Histopathological analysis of target organs showed that the number of megakaryocytes in the spleen was significantly increased, and pulmonary hyperemia and interstitial thickening were observed in the lungs. Nearly 35% of the injected SiNPs were distributed in the spleen, 12.5% in the liver, and 2% in the lung of SNP-treated mice.

At 24 h of post-intravenous administration (30 mg/kg bw), TEM imaging of the BALB/c mice tissues showed that 70-nm SiNPs were localized in the regional lymph nodes, cerebral cortex, hippocampus, and the cytoplasm, and nucleus of hepatocytes (liver). Using in vivo imaging, the authors also found that the SiNPs were distributed near the liver immediately after the administration (20 min) and moved near the intestinal tract over time (6 h). Micron-sized silica particles (300 and 1000 nm) used in these studies were accumulated mainly around the gall bladder (Nabeshi et al. [@CR74]).

A significant increase in the levels of kidney injury bio-markers such as BUN and CREA and morphological changes associated with renal interstitial fibrosis was noticed in BALB/c mice intraperitoneally treated with 198-nm M-SiNPs (150, 300, or 600 mg/kg bw for 2 or 12 days). There was also a significant increase in the levels of fibronectin (FN), TGF-β and ICAM-1, and nuclear translocation of p65 in 300- or 600-mg/kg treated mice (Chen et al. [@CR8]).

Zhuravskii et al. ([@CR92]) demonstrated that intravenously injected (70 mg/kg bw) Py-SiNPs (13 ± 5 nm) distributed and persisted in the liver of Wistar rats at 60-day post-administration. The authors also indicated that the administered SiNPs induced fibrosis and liver tissue remodeling by noticing the increase in blood ALT, and presence of mast cells, connective tissues, and foreign body-type granulomas in the liver.

### Conclusion: in vivo {#Sec50}

The in vivo toxicity studies have been carried out using rats and mice, and exposure through various routes of administration. In general, short-term exposure to SiNPs induced adverse effects in the lungs, kidneys, liver, and brain. SiNPs administered mainly via inhalation, ingestion, and intravenous routes were majorly distributed in the liver, lungs, spleen, and kidneys, and in the brain of the intranasally exposed rats. Most of the administered SiNPs were excreted via feces and to a lesser extent via urine, in a size- and shape-dependent manner. However, in most cases, the administered doses were very high compared to relevant human inhalation (Barsan [@CR5]) and ingestion (Winkler et al. [@CR92]; Dekkers et al. [@CR14]) exposures to amorphous silica. Some studies showed accumulation of SiNPs in organs such as the liver, but such accumulation was not associated with any major effects. However, long-term effects of accumulated SiNPs were not studied. It is surprising that in contrast to acute studies, no toxicity (local or systemic) was observed in chronic oral and dermal exposure studies, regardless of the size of SiNPs and the high doses used. Moreover, surface-modified SiNPs showed a significant increase in absorption by the GI tract compared to bare SiNPs. Dosing SiNPs via i.v. showed in all studies some sign of damage/toxicity. No clear type-or size-dependent effect can be identified from the set of reviewed studies. Furthermore, where genotoxicity was studied, it was not clear whether SiNPs were taken up by the target cells or were able to reach the tissue examined, which is obviously needed to exert a direct genotoxic effect.

Discussion {#Sec51}
==========

Growing production and use of SiNPs increase the risk of human exposures. Available toxicity studies mainly focused on effects after exposure via inhalation or skin (occupational exposure), ingestion (food additive), or nano-therapeutics (parenteral exposure). In vitro and in vivo studies demonstrated that SiNPs can induce adverse effects, but multiple 'inconsistencies' were found in the collected toxicity data set. As small differences in the physico-chemical properties of SiNPs could contribute to significant variation in the toxicity (Napierska et al. [@CR75]), it is critical to discriminate how these variations influence toxicity. It is also worthy to note that the choice of cell type, culture system, assay conditions (Fede et al. [@CR28]; Geys et al. [@CR33]; Hayashi et al. [@CR42]), and exposure route influence the toxic responses to SiNPs. However, the nature of these variations remains unclear, which continues to limit our understanding of SiNPs toxicity and hampers their hazard assessment.

Physico-chemical characterization {#Sec52}
---------------------------------

In this review, a basic set of physico-chemical characteristics of primary SiNPs such as primary size, shape, crystallinity, and chemical composition (or) purity was set as inclusion criteria. Most studies associated the toxic endpoints to SiNPs size, while only a few related the toxicity to SiNPs porosity, shape, surface charge, and surface chemistry. Furthermore, hydrodynamic diameter is another widely reported property in these studies and the results suggest that, in most cases, SiNPs are often aggregated/agglomerated (AA) in cell culture media. Conversely, AA formation is also very likely in real-world matrices such as in air (Kim et al. [@CR50]), water, and in commercial products such as food (Dekkers et al. [@CR14]). Such AA formation not only substantially alters the overall characteristics (such as size, shape and surface topology) but also potentially influences the biological outcomes (Luyts et al. [@CR64]; Drescher et al. [@CR20]). Although some progress has been made in the characterization of SiNPs AA in recent years (De Temmerman et al. [@CR13]), their biological effects remain poorly understood.

Toxicity of different types of SiNPs {#Sec53}
------------------------------------

Synthetic amorphous SiNPs are produced via different methods such as thermal (pyrogenic) or wet route (colloidal, precipitated and gel). The physico-chemical characteristics of SiNPs produced by these methods differ (Fruijtier-Pölloth [@CR30]; Napierska et al. [@CR75]) and may influence the biological outcomes. In this review, nearly 70% of the papers clearly reported the synthesis method. Among those 70%, about 80% reported the toxicity of wet method based SiNPs and only approximately 20% on the other types (such as pyrogenic and mesoporous). A general overview of toxic effects induced by different types of SiNPs is presented in Table [3](#Tab3){ref-type="table"}. Cytotoxicity and genotoxicity induced by S- and C-SiNPs are strongly correlated with the induction of oxidative stress. For Pr-SiNPs, oxidative stress was associated with cytotoxicity but not genotoxicity. Interestingly, Py-SiNPs caused cytotoxicity, mostly without the generation of oxidative stress. In addition, recent studies showed that Py-SiNPs are biologically more reactive than C-SiNPs (Zhang et al. [@CR92]) and Pr-SiNPs (Di Cristo et al. [@CR18]) of same composition and size. It is known that C-, S-, and Pr-SiNPs are hydrophilic in nature, while Py-SiNPs are hydrophobic due to the de-hydroxylation of surface OH groups during the production process (Napierska et al. [@CR75]), and such difference in surface chemistries might contribute to different biological activities. However, more systematic studies are required to verify these differences depending on production processes.

Toxicity mechanisms of amorphous SiNPs and crystalline silica {#Sec54}
-------------------------------------------------------------

A fundamental question was raised by Napierska et al. ([@CR75]): do amorphous SiNPs induce biological responses similar to crystalline silica? Oxidative DNA and membrane damage have been reported as the major toxic mechanisms involved in the health effects of micron-sized crystalline silica, which is also observed for C- and Pr-SiNPs. The latter two possess silanols on the surface while Py-SiNPs mostly contain siloxanes (Napierska et al. [@CR75]). In addition, recent studies showed that the presence of surface moieties such as silanols is more correlated with crystalline silica toxicity than crystallinity (Zhang et al. [@CR92]; Turci et al. [@CR92]). Thus, silanols appear to be a common surface feature in C-SiNPs, Pr-SiNPs, and crystalline silica, which might contribute to a similar toxic activity. Furthermore, toxicity elicited by Py-SiNPs appears to be *oxidative stress*-*independent*, indicating that Py-SiNPs induce adverse effects via other mechanisms (Gehrke et al. [@CR32]; Napierska et al. [@CR76]). More studies are required to verify these hypotheses.

Influence of exposure routes in vivo {#Sec55}
------------------------------------

The exposure route obviously influences the in vivo absorption, biodistribution, and toxicity of SiNPs. For instance, after oropharyngeal aspiration or intratracheal instillation, the lungs are clearly the main target (Smulders et al. [@CR92]), while after ingestion (Zande et al. [@CR92]) or iv injection (Yu et al. [@CR92]), the liver and/or the spleen were the targets. SiNPs accumulated in the brain of intranasally exposed rats (Parveen et al. [@CR86]) but did not after oral exposure (Shim et al. [@CR92]). In addition to the exposure route, physico-chemical properties such as size and shape clearly influence the clearance, distribution, and toxicity (Huang et al. [@CR44]; Li et al. [@CR58]).

Adverse effects of chronic exposure in vivo {#Sec56}
-------------------------------------------

In repeated (oral and dermal) dose studies (≥28 days), SiNPs did not induce any local or systemic toxicity even in (very) highly dosed rats. A recent study demonstrated that mild and highly dosed rats excreted most of the orally administered SiNPs via the feces (Yun et al. [@CR92]). In addition, Van der Zande et al. ([@CR92]) demonstrated the in vitro gelation of SiNPs with increasing concentrations, which might reduce the gastro-intestinal absorption in highly dosed animals and increase excretion via feces. Therefore, the use of (low) realistic exposure doses appears more appropriate, since the toxicokinetics may depend on the level of exposure (Paek et al. [@CR83]). Moreover, information on the physico-chemical properties of ingested and digested SiNPs is lacking, representing a huge knowledge gap in the risk assessment of SiNPs in food (Dekkers et al. [@CR15]).

Correlation between in vitro and in vivo studies {#Sec57}
------------------------------------------------

Correlation between in vitro and in vivo effects is an indication that specific cells or tissues are potential targets for SiNPs toxicity. The results of in vitro and in vivo experiments (included within the same study) suggest that exposure to SiNPs could induce Kupffer cell mediated liver injury (Chen et al. [@CR7]), kidney injury via the activation of NF-kB signaling pathways (Chen et al. [@CR8]), and endothelial dysfunction via autophagy (Duan et al. [@CR24]). Several in vitro studies showed that SiNPs caused DNA double-strand breaks in a wide range of immortalized cell lines at low doses, but no such genotoxic effects were observed, even in animals at high doses. In addition, SiNPs did not induce micronuclei either in vitro or in vivo.

Dosimetry in vitro {#Sec58}
------------------

Accurate in vitro dosimetry is an important yet complex aspect of nanotoxicology (Lison et al. [@CR62]). In many studies reviewed here, authors often tested high in vitro exposure doses. Considering the exposure dose as nominal dose may be appropriate only for well dispersed and stable SiNP suspensions (Lison et al. [@CR61]). However, Py-SiNPs, for instance, often re-agglomerate in culture media with an effective density lower than the material density (Deloid et al. [@CR16]), thereby potentially affecting the dose reaching the cells (Cohen et al. [@CR10]). Thus, a realistic estimation of the delivered dose is necessary to compare the biological effects between studies and to establish good in vitro and in vivo correlations (Pal et al. [@CR84]).

Physico-chemical properties for the safer design of SiNPs {#Sec59}
---------------------------------------------------------

Immune responses after the administration of SiNPs are very crucial, as they can induce cascades of events by the secretion of cytokines, which may be harmful or beneficial. The data collected in this review show that the smaller the size, the stronger the pro-inflammatory effect. In addition to the size, the surface charge appears to play a role, since less negative charges seem to suppress the immune response. Porosity is another crucial factor influencing blood biocompatibility, i.e., the more porous the SiNPs, the less hemolysis of RBCs (Maurer-jones et al. [@CR68]). Furthermore, SiNPs aspect ratio was shown to closely relate to in vivo organ retention and clearance (Huang et al. [@CR44]). Therefore, the size, surface area, porosity, and geometry (shape) appear to be the key parameters for designing less-toxic and less-inflammagenic SiNPs, for bio-medical applications for instance.

In conclusion, SiNPs generally exhibit acute toxic effects in vitro and in vivo. The data on chronic effects of SiNPs exposure are rather conflicting with the acute effects and are still insufficient to draw firm conclusions. No concrete data were found to conclude whether amorphous SiNPs induce fibrosis like micrometric crystalline silica. Moreover, translation to human health effects is impossible at this moment due to the lack of realistic exposure and epidemiological data. Surface moieties (such as silanols, silanolates, and siloxanes) of SiNPs are found to be production process-specific and seem to be the key determinants of SiNPs toxicity. AA formation for some SiNPs is very dynamic in physiological media, but it is still unclear how it contributes to the hazard characterization. Therefore, the design of safe(r) SiNPs for food, medical, and other applications will only be possible when physico-chemical characteristics can be unambiguously linked to toxicity. Furthermore, detailed investigations on the SNP bioaccumulation/bioavailability and their long-term consequences in vivo are required for a safer use.
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